JPS6223753B2 - - Google Patents
Info
- Publication number
- JPS6223753B2 JPS6223753B2 JP53127466A JP12746678A JPS6223753B2 JP S6223753 B2 JPS6223753 B2 JP S6223753B2 JP 53127466 A JP53127466 A JP 53127466A JP 12746678 A JP12746678 A JP 12746678A JP S6223753 B2 JPS6223753 B2 JP S6223753B2
- Authority
- JP
- Japan
- Prior art keywords
- compounds
- acid
- imidazolyl
- hours
- histamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 71
- 150000001875 compounds Chemical class 0.000 claims description 66
- -1 5-imidazolyl halomethyl ketone Chemical class 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 21
- 230000002829 reductive effect Effects 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 5
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 4
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 claims description 3
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 claims description 3
- 150000003949 imides Chemical class 0.000 claims description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 52
- 239000000243 solution Substances 0.000 description 44
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 37
- 229960001340 histamine Drugs 0.000 description 35
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 108010014095 Histidine decarboxylase Proteins 0.000 description 10
- 102100037095 Histidine decarboxylase Human genes 0.000 description 10
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 9
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 8
- 239000012267 brine Substances 0.000 description 8
- 229960002885 histidine Drugs 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- AXLRKQHOEWAMSP-UHFFFAOYSA-N [3-(4-methylphenyl)sulfonylimidazol-4-yl]methyl acetate Chemical compound CC(=O)OCC1=CN=CN1S(=O)(=O)C1=CC=C(C)C=C1 AXLRKQHOEWAMSP-UHFFFAOYSA-N 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ZTFICESHHXHCLB-UHFFFAOYSA-N (2-fluoro-1h-imidazol-5-yl)methanol Chemical compound OCC1=CN=C(F)N1 ZTFICESHHXHCLB-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000024780 Urticaria Diseases 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- RWRIWBAIICGTTQ-UHFFFAOYSA-N difluoromethane Chemical compound FCF RWRIWBAIICGTTQ-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000003630 histaminocyte Anatomy 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 230000009610 hypersensitivity Effects 0.000 description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- KEEZVRAORFFYPZ-UHFFFAOYSA-N 1,1-difluoro-3-(1h-imidazol-5-yl)propan-2-amine Chemical compound FC(F)C(N)CC1=CN=CN1 KEEZVRAORFFYPZ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- XPYGFPAXOSJDKI-UHFFFAOYSA-N [3-(4-methylphenyl)sulfonylimidazol-4-yl]methanol Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CO)=CN=C1 XPYGFPAXOSJDKI-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 229940125715 antihistaminic agent Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 230000004963 pathophysiological condition Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- JNMJOYZNBDRVDG-UHFFFAOYSA-N (1-propan-2-ylimidazol-4-yl)methanol Chemical compound CC(C)N1C=NC(CO)=C1 JNMJOYZNBDRVDG-UHFFFAOYSA-N 0.000 description 2
- ZJPCLNLMECIJKX-UHFFFAOYSA-N (2,5-dimethyl-1h-imidazol-4-yl)methanol Chemical compound CC1=NC(C)=C(CO)N1 ZJPCLNLMECIJKX-UHFFFAOYSA-N 0.000 description 2
- WKIGVYWGXYLOTK-ZCFIWIBFSA-N (2r)-2-amino-2-hydrazinyl-3-(1h-imidazol-5-yl)propanoic acid Chemical compound NN[C@@](N)(C(O)=O)CC1=CNC=N1 WKIGVYWGXYLOTK-ZCFIWIBFSA-N 0.000 description 2
- ZGGZWKAYCZIITN-UHFFFAOYSA-N 1,1,1-trifluoro-3-[3-(4-methylphenyl)sulfonylimidazol-4-yl]propan-2-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CC(=O)C(F)(F)F)=CN=C1 ZGGZWKAYCZIITN-UHFFFAOYSA-N 0.000 description 2
- QAPXLUZMMFIIBI-UHFFFAOYSA-N 1,1,3,3-tetrafluoropropan-2-one Chemical class FC(F)C(=O)C(F)F QAPXLUZMMFIIBI-UHFFFAOYSA-N 0.000 description 2
- KSASLGQSTVCVRC-UHFFFAOYSA-N 1-fluoro-3-(1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.FCC(N)CC1=CN=CN1 KSASLGQSTVCVRC-UHFFFAOYSA-N 0.000 description 2
- MZZNXSMNNJQDFH-UHFFFAOYSA-N 1-fluoro-3-(2-fluoro-1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.FCC(N)CC1=CN=C(F)N1 MZZNXSMNNJQDFH-UHFFFAOYSA-N 0.000 description 2
- PMXJEXKLSXDERZ-UHFFFAOYSA-N 1-fluoro-3-[3-(4-methylphenyl)sulfonylimidazol-4-yl]propan-2-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CC(=O)CF)=CN=C1 PMXJEXKLSXDERZ-UHFFFAOYSA-N 0.000 description 2
- OZQNRSVQPOEZBQ-UHFFFAOYSA-N 1h-imidazol-5-ylmethylphosphane Chemical class PCC1=CNC=N1 OZQNRSVQPOEZBQ-UHFFFAOYSA-N 0.000 description 2
- BBZYSPFBMHSVDI-UHFFFAOYSA-N 2-(2-propan-2-yl-1h-imidazol-5-yl)acetonitrile Chemical compound CC(C)C1=NC=C(CC#N)N1 BBZYSPFBMHSVDI-UHFFFAOYSA-N 0.000 description 2
- GLRWMNTVXCSXSO-UHFFFAOYSA-N 2-[3-(4-methylphenyl)sulfonyl-2-propan-2-ylimidazol-4-yl]acetic acid Chemical compound CC(C)C1=NC=C(CC(O)=O)N1S(=O)(=O)C1=CC=C(C)C=C1 GLRWMNTVXCSXSO-UHFFFAOYSA-N 0.000 description 2
- RMOYNLGOJQMJAE-UHFFFAOYSA-N 5-(2-ethoxy-3,3,3-trifluoroprop-1-enyl)-1-(4-methylphenyl)sulfonylimidazole Chemical compound CCOC(C(F)(F)F)=CC1=CN=CN1S(=O)(=O)C1=CC=C(C)C=C1 RMOYNLGOJQMJAE-UHFFFAOYSA-N 0.000 description 2
- RDDHQCTZCTVXBA-UHFFFAOYSA-N 5-(chloromethyl)-2-propan-2-yl-1h-imidazole;hydrochloride Chemical compound Cl.CC(C)C1=NC=C(CCl)N1 RDDHQCTZCTVXBA-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 208000028185 Angioedema Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004031 Carboxy-Lyases Human genes 0.000 description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 2
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- CBLYYMUEZITYCZ-UHFFFAOYSA-N N1C=NC=C1C=[PH3] Chemical compound N1C=NC=C1C=[PH3] CBLYYMUEZITYCZ-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 208000036284 Rhinitis seasonal Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000003441 Transfusion reaction Diseases 0.000 description 2
- 206010052568 Urticaria chronic Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 description 2
- NJILZLLNJKXPGF-UHFFFAOYSA-N [2-fluoro-3-(4-methylphenyl)sulfonylimidazol-4-yl]methyl acetate Chemical compound CC(=O)OCC1=CN=C(F)N1S(=O)(=O)C1=CC=C(C)C=C1 NJILZLLNJKXPGF-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 208000024376 chronic urticaria Diseases 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002497 edematous effect Effects 0.000 description 2
- PNZDZRMOBIIQTC-UHFFFAOYSA-N ethanamine;hydron;bromide Chemical compound Br.CCN PNZDZRMOBIIQTC-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 201000000052 gastrinoma Diseases 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- QDYTUZCWBJRHKK-UHFFFAOYSA-N imidazole-4-methanol Chemical class OCC1=CNC=N1 QDYTUZCWBJRHKK-UHFFFAOYSA-N 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N ortho-diethylbenzene Natural products CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- BLPWCLBWWYDASB-UHFFFAOYSA-N (4-ethyl-1h-imidazol-5-yl)methanol Chemical compound CCC=1N=CNC=1CO BLPWCLBWWYDASB-UHFFFAOYSA-N 0.000 description 1
- DFERLZBSNUJLIT-UHFFFAOYSA-N (4-ethyl-2-propan-2-ylimidazol-4-yl)methanol Chemical compound CCC1(CO)C=NC(C(C)C)=N1 DFERLZBSNUJLIT-UHFFFAOYSA-N 0.000 description 1
- IETWVRUKWUZOSV-UHFFFAOYSA-N (4-propan-2-yl-1h-imidazol-5-yl)methanol Chemical compound CC(C)C=1NC=NC=1CO IETWVRUKWUZOSV-UHFFFAOYSA-N 0.000 description 1
- OTKFCIVOVKCFHR-UHFFFAOYSA-N (Methylsulfinyl)(methylthio)methane Chemical compound CSCS(C)=O OTKFCIVOVKCFHR-UHFFFAOYSA-N 0.000 description 1
- BWBOMFGNXUTSTD-UHFFFAOYSA-N 1,1,1-trifluoro-3-(2-fluoro-1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.FC(F)(F)C(N)CC1=CN=C(F)N1 BWBOMFGNXUTSTD-UHFFFAOYSA-N 0.000 description 1
- JYUASDLKGNPWQC-UHFFFAOYSA-N 1,1,1-trifluoro-3-(2-propan-2-yl-1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.CC(C)C1=NC=C(CC(N)C(F)(F)F)N1 JYUASDLKGNPWQC-UHFFFAOYSA-N 0.000 description 1
- SHJIFHVUENLYQK-UHFFFAOYSA-N 1,1-difluoro-3-(2-fluoro-1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.FC(F)C(N)CC1=CN=C(F)N1 SHJIFHVUENLYQK-UHFFFAOYSA-N 0.000 description 1
- BBFUBPLLVJKMEI-UHFFFAOYSA-N 1,1-difluoro-3-(2-fluoro-1h-imidazol-5-yl)propan-2-one Chemical compound FC(F)C(=O)CC1=CN=C(F)N1 BBFUBPLLVJKMEI-UHFFFAOYSA-N 0.000 description 1
- SAKKXDVPEYDYJS-UHFFFAOYSA-N 1,1-difluoro-3-(2-propan-2-yl-1h-imidazol-5-yl)propan-2-amine;hydrobromide Chemical compound Br.CC(C)C1=NC=C(CC(N)C(F)F)N1 SAKKXDVPEYDYJS-UHFFFAOYSA-N 0.000 description 1
- DYSSSTLDVUTGCJ-UHFFFAOYSA-N 1,1-difluoro-3-[2-fluoro-3-(4-methylphenyl)sulfonylimidazol-4-yl]propan-2-one Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CC(=O)C(F)F)=CN=C1F DYSSSTLDVUTGCJ-UHFFFAOYSA-N 0.000 description 1
- PZLQZYUXJJJTJC-UHFFFAOYSA-N 1,1-difluoro-3-[3-(4-methylphenyl)sulfonyl-2,5-di(propan-2-yl)imidazol-4-yl]propan-2-one Chemical compound FC(F)C(=O)CC1=C(C(C)C)N=C(C(C)C)N1S(=O)(=O)C1=CC=C(C)C=C1 PZLQZYUXJJJTJC-UHFFFAOYSA-N 0.000 description 1
- ZMZCYSXYBUNSRF-UHFFFAOYSA-N 1,1-difluoro-3-[3-(4-methylphenyl)sulfonyl-2-propan-2-ylimidazol-4-yl]propan-2-one Chemical compound CC(C)C1=NC=C(CC(=O)C(F)F)N1S(=O)(=O)C1=CC=C(C)C=C1 ZMZCYSXYBUNSRF-UHFFFAOYSA-N 0.000 description 1
- SKDFWEPBABSFMG-UHFFFAOYSA-N 1,2-dichloro-1,1-difluoroethane Chemical compound FC(F)(Cl)CCl SKDFWEPBABSFMG-UHFFFAOYSA-N 0.000 description 1
- GOKAPRQWYXFXRR-UHFFFAOYSA-N 1-(2,5-dimethyl-1h-imidazol-4-yl)-3-fluoropropan-2-amine;hydrobromide Chemical compound Br.CC1=NC(C)=C(CC(N)CF)N1 GOKAPRQWYXFXRR-UHFFFAOYSA-N 0.000 description 1
- NWBCRWCKZUXDNV-UHFFFAOYSA-N 1-(ethylsulfinylmethylsulfanyl)ethane Chemical compound CCSCS(=O)CC NWBCRWCKZUXDNV-UHFFFAOYSA-N 0.000 description 1
- QCUWDFHIYJYISA-UHFFFAOYSA-N 1-[2,4-di(propan-2-yl)-1h-imidazol-5-yl]-3-fluoropropan-2-amine;hydrobromide Chemical compound Br.CC(C)C1=NC(C(C)C)=C(CC(N)CF)N1 QCUWDFHIYJYISA-UHFFFAOYSA-N 0.000 description 1
- MTPASQAFTUVPTN-UHFFFAOYSA-N 1-fluoro-3-[3-(4-methylphenyl)sulfonyl-2-propan-2-ylimidazol-4-yl]propan-2-one Chemical compound CC(C)C1=NC=C(CC(=O)CF)N1S(=O)(=O)C1=CC=C(C)C=C1 MTPASQAFTUVPTN-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DWFVOYGDFIDRJK-UHFFFAOYSA-N 1h-imidazol-5-ylmethyl acetate Chemical class CC(=O)OCC1=CN=CN1 DWFVOYGDFIDRJK-UHFFFAOYSA-N 0.000 description 1
- XLYUUKKYQSDWJQ-UHFFFAOYSA-N 2-(2-propan-2-yl-1h-imidazol-5-yl)acetic acid;hydrochloride Chemical compound Cl.CC(C)C1=NC=C(CC(O)=O)N1 XLYUUKKYQSDWJQ-UHFFFAOYSA-N 0.000 description 1
- TYRGLVWXHJRKMT-UHFFFAOYSA-N 2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC(=O)C(C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- AUXYZUDAFXEUQY-UHFFFAOYSA-N 2-[3-(4-methylphenyl)sulfonyl-2-propan-2-ylimidazol-4-yl]acetyl chloride Chemical compound CC(C)C1=NC=C(CC(Cl)=O)N1S(=O)(=O)C1=CC=C(C)C=C1 AUXYZUDAFXEUQY-UHFFFAOYSA-N 0.000 description 1
- KDJPCEROCKXLBF-UHFFFAOYSA-N 2-[3-(4-methylphenyl)sulfonylimidazol-4-yl]acetyl chloride Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CC(Cl)=O)=CN=C1 KDJPCEROCKXLBF-UHFFFAOYSA-N 0.000 description 1
- BQCMSZGUOSRIJA-UHFFFAOYSA-N 2-amino-n-[1-fluoro-3-(1h-imidazol-5-yl)propan-2-yl]propanamide Chemical compound CC(N)C(=O)NC(CF)CC1=CN=CN1 BQCMSZGUOSRIJA-UHFFFAOYSA-N 0.000 description 1
- SCNWTQPZTZMXBG-UHFFFAOYSA-N 2-methyloct-2-enoic acid Chemical compound CCCCCC=C(C)C(O)=O SCNWTQPZTZMXBG-UHFFFAOYSA-N 0.000 description 1
- OEHADTKWRQEBOO-UHFFFAOYSA-N 3-(2,5-dimethyl-1h-imidazol-4-yl)-1,1,1-trifluoropropan-2-amine;hydrobromide Chemical compound Br.CC1=NC(C)=C(CC(N)C(F)(F)F)N1 OEHADTKWRQEBOO-UHFFFAOYSA-N 0.000 description 1
- VGWAPXQMFZAEMQ-UHFFFAOYSA-N 3-(2,5-dimethyl-1h-imidazol-4-yl)-1,1-difluoropropan-2-amine;hydrobromide Chemical compound Br.CC1=NC(C)=C(CC(N)C(F)F)N1 VGWAPXQMFZAEMQ-UHFFFAOYSA-N 0.000 description 1
- MVDJVHMAKLGHOQ-UHFFFAOYSA-N 3-(2,5-dimethyl-1h-imidazol-4-yl)-1,1-difluoropropan-2-one Chemical compound CC1=NC(C)=C(CC(=O)C(F)F)N1 MVDJVHMAKLGHOQ-UHFFFAOYSA-N 0.000 description 1
- WOQMRJCOGCXSGK-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[[2-[4-(chloromethyl)phenyl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N(C2=O)C1C2NC(=O)CC1=CC=C(CCl)C=C1 WOQMRJCOGCXSGK-UHFFFAOYSA-N 0.000 description 1
- SRGHTFZLFUJHFW-UHFFFAOYSA-N 3-[2,4-di(propan-2-yl)-1h-imidazol-5-yl]-1,1,1-trifluoropropan-2-amine;hydrobromide Chemical compound Br.CC(C)C1=NC(C(C)C)=C(CC(N)C(F)(F)F)N1 SRGHTFZLFUJHFW-UHFFFAOYSA-N 0.000 description 1
- YNYAIUMZJZFMPK-UHFFFAOYSA-N 3-[2,4-di(propan-2-yl)-1h-imidazol-5-yl]-1,1-difluoropropan-2-amine;hydrobromide Chemical compound Br.CC(C)C1=NC(C(C)C)=C(CC(N)C(F)F)N1 YNYAIUMZJZFMPK-UHFFFAOYSA-N 0.000 description 1
- KWOQDVFWYCRFHL-UHFFFAOYSA-N 3-[2,4-di(propan-2-yl)-1h-imidazol-5-yl]-1,1-difluoropropan-2-one Chemical compound CC(C)C1=NC(C(C)C)=C(CC(=O)C(F)F)N1 KWOQDVFWYCRFHL-UHFFFAOYSA-N 0.000 description 1
- FOZZUCVRXSTUAH-UHFFFAOYSA-N 3-[2,5-dimethyl-3-(4-methylphenyl)sulfonylimidazol-4-yl]-1,1-difluoropropan-2-one Chemical compound FC(F)C(=O)CC1=C(C)N=C(C)N1S(=O)(=O)C1=CC=C(C)C=C1 FOZZUCVRXSTUAH-UHFFFAOYSA-N 0.000 description 1
- WRFYIYOXJWKONR-UHFFFAOYSA-N 4-bromo-2-methoxyaniline Chemical compound COC1=CC(Br)=CC=C1N WRFYIYOXJWKONR-UHFFFAOYSA-N 0.000 description 1
- OLBDLWKZMRTWKB-UHFFFAOYSA-N 5-[ethylsulfanyl(ethylsulfinyl)methyl]-1-(4-methylphenyl)sulfonylimidazole Chemical compound CCSC(S(=O)CC)C1=CN=CN1S(=O)(=O)C1=CC=C(C)C=C1 OLBDLWKZMRTWKB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 description 1
- 241000207062 Candidatus Hepatobacter Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- FBVJRPMNVYACPK-UHFFFAOYSA-N FC=1NC(=CN=1)CC(F)(F)C(=O)C(CC1=CN=C(N1)F)(F)F Chemical compound FC=1NC(=CN=1)CC(F)(F)C(=O)C(CC1=CN=C(N1)F)(F)F FBVJRPMNVYACPK-UHFFFAOYSA-N 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000577483 Salmonella enterica subsp. enterica serovar Paratyphi B Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000034699 Vitreous floaters Diseases 0.000 description 1
- GWWLARMYMKTTJS-UHFFFAOYSA-N [2,4-di(propan-2-yl)-1h-imidazol-5-yl]methanol Chemical compound CC(C)C1=NC(C(C)C)=C(CO)N1 GWWLARMYMKTTJS-UHFFFAOYSA-N 0.000 description 1
- MYWYOLWYTFGFQD-UHFFFAOYSA-N [2,5-dimethyl-3-(4-methylphenyl)sulfonylimidazol-4-yl]methyl acetate Chemical compound CC(=O)OCC1=C(C)N=C(C)N1S(=O)(=O)C1=CC=C(C)C=C1 MYWYOLWYTFGFQD-UHFFFAOYSA-N 0.000 description 1
- VFMKXHARRZJLLI-UHFFFAOYSA-N [3-(4-methylphenyl)sulfonyl-2,5-di(propan-2-yl)imidazol-4-yl]methyl acetate Chemical compound CC(=O)OCC1=C(C(C)C)N=C(C(C)C)N1S(=O)(=O)C1=CC=C(C)C=C1 VFMKXHARRZJLLI-UHFFFAOYSA-N 0.000 description 1
- RXHJLMRVIZBHIX-UHFFFAOYSA-N [3-(4-methylphenyl)sulfonyl-2-propan-2-ylimidazol-4-yl]methyl acetate Chemical compound CC(C)C1=NC=C(COC(C)=O)N1S(=O)(=O)C1=CC=C(C)C=C1 RXHJLMRVIZBHIX-UHFFFAOYSA-N 0.000 description 1
- WJGAPUXHSQQWQF-UHFFFAOYSA-N acetic acid;hydrochloride Chemical compound Cl.CC(O)=O WJGAPUXHSQQWQF-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- HRRYYCWYCMJNGA-ZETCQYMHSA-N alpha-methyl-L-histidine Chemical compound OC(=O)[C@](N)(C)CC1=CN=CN1 HRRYYCWYCMJNGA-ZETCQYMHSA-N 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- TXHIDIHEXDFONW-UHFFFAOYSA-N benzene;propan-2-one Chemical compound CC(C)=O.C1=CC=CC=C1 TXHIDIHEXDFONW-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- YAZGWRJUOMKYGM-UHFFFAOYSA-N benzyl 5-(2-amino-3-fluoropropyl)imidazole-1-carboxylate Chemical compound FCC(N)CC1=CN=CN1C(=O)OCC1=CC=CC=C1 YAZGWRJUOMKYGM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HANNRODODRCYTN-UHFFFAOYSA-N benzyl n-[1-fluoro-3-(1h-imidazol-5-yl)propan-2-yl]carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC(CF)CC1=CN=CN1 HANNRODODRCYTN-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GRCDJFHYVYUNHM-UHFFFAOYSA-N bromodifluoromethane Chemical compound FC(F)Br GRCDJFHYVYUNHM-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 description 1
- 229950004030 cefaloglycin Drugs 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003954 decarboxylase inhibitor Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 125000004970 halomethyl group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WFNASTYGEKUMIY-UHFFFAOYSA-N hydron;1h-imidazol-5-ylmethanol;chloride Chemical compound Cl.OCC1=CN=CN1 WFNASTYGEKUMIY-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 1
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- FGELYTUNHSVOEG-UHFFFAOYSA-N n-[1-fluoro-3-(1h-imidazol-5-yl)propan-2-yl]acetamide Chemical compound CC(=O)NC(CF)CC1=CN=CN1 FGELYTUNHSVOEG-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007892 solid unit dosage form Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000002568 urticarial effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãæ°èŠãªè£œè¬åŠçã«æçšãªãã¹ã¿ãã³
ã®ããã¡ãã«èªå°äœåã³é¢é£ååç©ã«é¢ãããã®
ã§ããã
ã®ããã¡ãã«èªå°äœåã³é¢é£ååç©ã«é¢ãããã®
ã§ããã
å€ãã®åºä¹³åç©çµç¹ã«ã¯ãã¹ã¿ãã³ãå«ãŸããŠ
ããããã®æ¿åºŠã¯ç®èãè žç²èåã³èºäžã§ç¹ã«é«
ããçœè¡çãå«ããŠãã¹ã¿ãã³ãå«æããŠããå š
ãŠã®åºä¹³åç©çµç¹ã¯ãã¹ããžã³ããã¢ãã³ãåæ
ã§ããããã«ã¿ãããçäœäžã§ãã¹ããžã³ã®ãã¹
ã¿ãã³ãžã®è»¢åã®è§Šåªäœçšã«é¢äžããäž»ãªé µçŽ
ã¯ãåºè³ªïŒ¬âãã¹ããžã³ã«å¯ŸããŠç¹ç°çãªãã¹ã
ãžã³ãã«ã«ããã·ã©ãŒãŒã§ãããå€ãã®çµç¹äžã§
ã¯ããã¹ã¿ãã³ã®äž»ãªè²¯èµäœçœ®ã¯è¥æºçŽ°èã§ã
ããåã¯è¡æ¶²ã®å Žåã«ã¯ãåºå®çµç¹è¥æºçŽ°èã®åŸª
ç°ããçžå¯Ÿç©ã§ãã奜塩åºçã§ããããã¹ã¿ãã³
ã¯äººéã®è¡šç®ãäžæ¢ç¥çµç³»åã³èè žç²èäžã«å®è³ª
çãªéã§ååšããŠãããããè¥æºçŽ°èã¯ãã¹ã¿ã
ã³ã®å¯äžã®çµç¹æºã§ã¯ãªãã
ããããã®æ¿åºŠã¯ç®èãè žç²èåã³èºäžã§ç¹ã«é«
ããçœè¡çãå«ããŠãã¹ã¿ãã³ãå«æããŠããå š
ãŠã®åºä¹³åç©çµç¹ã¯ãã¹ããžã³ããã¢ãã³ãåæ
ã§ããããã«ã¿ãããçäœäžã§ãã¹ããžã³ã®ãã¹
ã¿ãã³ãžã®è»¢åã®è§Šåªäœçšã«é¢äžããäž»ãªé µçŽ
ã¯ãåºè³ªïŒ¬âãã¹ããžã³ã«å¯ŸããŠç¹ç°çãªãã¹ã
ãžã³ãã«ã«ããã·ã©ãŒãŒã§ãããå€ãã®çµç¹äžã§
ã¯ããã¹ã¿ãã³ã®äž»ãªè²¯èµäœçœ®ã¯è¥æºçŽ°èã§ã
ããåã¯è¡æ¶²ã®å Žåã«ã¯ãåºå®çµç¹è¥æºçŽ°èã®åŸª
ç°ããçžå¯Ÿç©ã§ãã奜塩åºçã§ããããã¹ã¿ãã³
ã¯äººéã®è¡šç®ãäžæ¢ç¥çµç³»åã³èè žç²èäžã«å®è³ª
çãªéã§ååšããŠãããããè¥æºçŽ°èã¯ãã¹ã¿ã
ã³ã®å¯äžã®çµç¹æºã§ã¯ãªãã
ãã¹ã¿ãã³ã¯çš®ã
ã®çççéçšã«é¢äžããŠã
ãããã¹ã¿ãã³ã¯æåâæäœåå¿äžã«æŸåºããã
ãããŠããã¯ã倧éšåãè¡ç®¡æ¡åŒµãããã¿åã³æµ®
è «çæã«ããç¹åŸŽã¥ããããŠããéæäœã®åå ãš
ãªããé¢äžããŠããäž»ãªçŽ°èãè¥æºçŽ°èåã³å¥œå¡©
åºçã§ãããããããã¹ã¿ãã³ãæŸåºããããã
ãªåã®æåâæäœåå¿ã¯ãäžè¬ã«çŽæ¥çéæäœå
å¿ãšç§°ããããŠãããæåããªãã¡ã¢ã¬ã«ã²ã³ã®
ä»ã«ãã¹ã¿ãã³ã¯å€ãã®ååŠç©è³ªãé«ååç©è³ªã
æ¯æ¶²ã身äœçå·å®³ãäŸãã°ç±åã³å·åºæ¿ã«ãã€ãŠ
ãæŸåºããããèé žåæ³ããã¹ã¿ãã³ã«ããåºæ¿
ããããããšãç¥ãããŠããããŸãããã¹ã¿ãã³
ãããã¿åã³ããã¿ãèªçºããæèŠåºæ¿ã®éå§ã«
é¢äžããŠããããšãç¥ãããŠãããæ¥éæé·ãã
å€ãã®çµç¹ãäŸãã°èå çµç¹ãåçèèåã³æªæ§
æé·äžã§ãã¹ã¿ãã³æ°Žæºãé«ãããšãèŠåºãããŠ
ããã
ãããã¹ã¿ãã³ã¯æåâæäœåå¿äžã«æŸåºããã
ãããŠããã¯ã倧éšåãè¡ç®¡æ¡åŒµãããã¿åã³æµ®
è «çæã«ããç¹åŸŽã¥ããããŠããéæäœã®åå ãš
ãªããé¢äžããŠããäž»ãªçŽ°èãè¥æºçŽ°èåã³å¥œå¡©
åºçã§ãããããããã¹ã¿ãã³ãæŸåºããããã
ãªåã®æåâæäœåå¿ã¯ãäžè¬ã«çŽæ¥çéæäœå
å¿ãšç§°ããããŠãããæåããªãã¡ã¢ã¬ã«ã²ã³ã®
ä»ã«ãã¹ã¿ãã³ã¯å€ãã®ååŠç©è³ªãé«ååç©è³ªã
æ¯æ¶²ã身äœçå·å®³ãäŸãã°ç±åã³å·åºæ¿ã«ãã€ãŠ
ãæŸåºããããèé žåæ³ããã¹ã¿ãã³ã«ããåºæ¿
ããããããšãç¥ãããŠããããŸãããã¹ã¿ãã³
ãããã¿åã³ããã¿ãèªçºããæèŠåºæ¿ã®éå§ã«
é¢äžããŠããããšãç¥ãããŠãããæ¥éæé·ãã
å€ãã®çµç¹ãäŸãã°èå çµç¹ãåçèèåã³æªæ§
æé·äžã§ãã¹ã¿ãã³æ°Žæºãé«ãããšãèŠåºãããŠ
ããã
çµç¹äžã§ã®ãã¹ã¿ãã³æ°Žæºãšãã¹ããžã³ãã«ã«
ããã·ã©ãŒãŒæŽ»æ§ã®éã®çžé¢é¢ä¿ãèªããããŠã
ãããã¹ã¿ãã³åã³ãã¹ããžã³ãã«ã«ããã·ã©ãŒ
ãŒãå«æããŠããè³äžã§ã¯ããã¹ã¿ãã³ã®å ¥ã代
ãã¯æ¥éã§ããããã€ãã¹ããžã³ãã«ã«ããã·ã©
ãŒãŒæŽ»æ§ãå¢å€§ãããç·åŒµæ§åºæ¿ã«ããå¢å€§ãã
ããâãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶
å€ãäŸãã°Î±âããã©ãžããã¹ããžã³ããã¹ã¿ã
ã³æ¿åºŠãäœäžããããããšã¯ç¥ãããŠãããé«æ°Ž
æºã®ãã¹ã¿ãã³ãååšããŠããããã¿ã®èå çµç¹
ã§ã¯ãâãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶
ãèå ã®æé·ãæ¢ããããšã瀺ãããŠããã
ããã·ã©ãŒãŒæŽ»æ§ã®éã®çžé¢é¢ä¿ãèªããããŠã
ãããã¹ã¿ãã³åã³ãã¹ããžã³ãã«ã«ããã·ã©ãŒ
ãŒãå«æããŠããè³äžã§ã¯ããã¹ã¿ãã³ã®å ¥ã代
ãã¯æ¥éã§ããããã€ãã¹ããžã³ãã«ã«ããã·ã©
ãŒãŒæŽ»æ§ãå¢å€§ãããç·åŒµæ§åºæ¿ã«ããå¢å€§ãã
ããâãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶
å€ãäŸãã°Î±âããã©ãžããã¹ããžã³ããã¹ã¿ã
ã³æ¿åºŠãäœäžããããããšã¯ç¥ãããŠãããé«æ°Ž
æºã®ãã¹ã¿ãã³ãååšããŠããããã¿ã®èå çµç¹
ã§ã¯ãâãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶
ãèå ã®æé·ãæ¢ããããšã瀺ãããŠããã
ãã¹ã¿ãã³ã®å¹æåã³ããã®äœçšåœ¢æ
ã¯ããè«
ããããŠãããã¢ãã³ã¯ãã®å¹æãH1åã³H2å
容äœãšåé¡ãããŠããå°ãªããšãïŒçš®ã®å容äœäž
ã«åãŒããŠãããšä¿¡ããããŠããããã¹ã¿ãã³ã®
å¹æã«æããæ°çš®ã®è©Šå€ãå ¬ç¥ã§ãããããã®ã
ããªè©Šå€ã®å šãŠããã¹ã¿ãã³ã®çæãé²ããã®ã§
ã¯ãªããäŸãã°ã¢ã¬ã«ã®ãŒåå¿ã®æ²»çã§æçšãªå€
å žçæãã¹ã¿ãã³é¡ã¯ãã¹ã¿ãã³ãšH1å容äœãš
ã®çµåã劚害ããããšã«ãããããã®æçšæ§ãçº
æ®ãããšä¿¡ããããŠãããèé žåæ³ã«å¯Ÿãããã¹
ã¿ãã³ã®è奮å¹æã®æå¶ã§äœ¿çšã§ããåæ§ãªè©Šè¬
ã¯ããã¹ã¿ãã³ãšH2å容äœãšã®çµåã劚害ãã
ããšã«ããäœçšãããšä¿¡ããããŠããã
ããããŠãããã¢ãã³ã¯ãã®å¹æãH1åã³H2å
容äœãšåé¡ãããŠããå°ãªããšãïŒçš®ã®å容äœäž
ã«åãŒããŠãããšä¿¡ããããŠããããã¹ã¿ãã³ã®
å¹æã«æããæ°çš®ã®è©Šå€ãå ¬ç¥ã§ãããããã®ã
ããªè©Šå€ã®å šãŠããã¹ã¿ãã³ã®çæãé²ããã®ã§
ã¯ãªããäŸãã°ã¢ã¬ã«ã®ãŒåå¿ã®æ²»çã§æçšãªå€
å žçæãã¹ã¿ãã³é¡ã¯ãã¹ã¿ãã³ãšH1å容äœãš
ã®çµåã劚害ããããšã«ãããããã®æçšæ§ãçº
æ®ãããšä¿¡ããããŠãããèé žåæ³ã«å¯Ÿãããã¹
ã¿ãã³ã®è奮å¹æã®æå¶ã§äœ¿çšã§ããåæ§ãªè©Šè¬
ã¯ããã¹ã¿ãã³ãšH2å容äœãšã®çµåã劚害ãã
ããšã«ããäœçšãããšä¿¡ããããŠããã
H1å容äœã劚害ããããšã®ã§ããè©Šè¬ã¯ãæ¥
æ§ã®æ»²åºæ§åã®ã¢ã¬ã«ã®ãŒãäŸãã°å£ç¯ç錻çã
æ¯èç±ãè±ç²çã®æ²»çã«ãããŠããããã¿ã錻
æŒãç®ã錻ãã®ã©ã®ããã¿ã軜æžããããã®çšé
ãèŠåºãããŠããããã®ãããªè©Šè¬ã¯å³ã®å¶åŸ¡ã«
ãããŠã䜿çšã§ãããããŠå šèº«çéæçåã³æ°ç®¡
æ¯åæ¯ã®æ²»çã«ãããŠãããçšåºŠã®çšéãèŠåºã
ããŠãããH1å容äœãä»ããŠäœçšããæãã¹ã¿
ãã³å€ã¯ãã¢ã¬ã«ã®ãŒæ§ç®èç ãäŸãã°æ¥æ§åã³
æ ¢æ§ãããŸãããè¡ç®¡æµ®è «ãççãäŸãã°éæ
æ§ç®èçåã³æ¥è§Šç®èçã®æ²»çã«ãããŠãè¡æž çŸ
ç ã®ãããŸããåã³æµ®è «ç å€ã®æ²»çã«ãããŠã茞
è¡åå¿ã®æ²»çã«ãããŠããããŠã¢ã¬ã«ã®ãŒæ§çŸè±¡
ã«ããè¬ååå¿ã®æ²»çã«ãããŠãæçšã§ããã
H2å容äœã劚害ããè©Šè¬ã¯ãæ¶ååšæœ°ç圢æã
ãŸãªã³ã²ã«âãšãªãœã³çå矀åã³ä»ã®èã®åæ³é
å€çã®æ²»çã«ãããŠãæçšã§ããã
æ§ã®æ»²åºæ§åã®ã¢ã¬ã«ã®ãŒãäŸãã°å£ç¯ç錻çã
æ¯èç±ãè±ç²çã®æ²»çã«ãããŠããããã¿ã錻
æŒãç®ã錻ãã®ã©ã®ããã¿ã軜æžããããã®çšé
ãèŠåºãããŠããããã®ãããªè©Šè¬ã¯å³ã®å¶åŸ¡ã«
ãããŠã䜿çšã§ãããããŠå šèº«çéæçåã³æ°ç®¡
æ¯åæ¯ã®æ²»çã«ãããŠãããçšåºŠã®çšéãèŠåºã
ããŠãããH1å容äœãä»ããŠäœçšããæãã¹ã¿
ãã³å€ã¯ãã¢ã¬ã«ã®ãŒæ§ç®èç ãäŸãã°æ¥æ§åã³
æ ¢æ§ãããŸãããè¡ç®¡æµ®è «ãççãäŸãã°éæ
æ§ç®èçåã³æ¥è§Šç®èçã®æ²»çã«ãããŠãè¡æž çŸ
ç ã®ãããŸããåã³æµ®è «ç å€ã®æ²»çã«ãããŠã茞
è¡åå¿ã®æ²»çã«ãããŠããããŠã¢ã¬ã«ã®ãŒæ§çŸè±¡
ã«ããè¬ååå¿ã®æ²»çã«ãããŠãæçšã§ããã
H2å容äœã劚害ããè©Šè¬ã¯ãæ¶ååšæœ°ç圢æã
ãŸãªã³ã²ã«âãšãªãœã³çå矀åã³ä»ã®èã®åæ³é
å€çã®æ²»çã«ãããŠãæçšã§ããã
ãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒäŸãã°Î±âã¡ã
ã«ãã¹ããžã³åã³Î±âããã©ãžããã¹ããžã³ã®æŽ»
æ§ãæå¶ããããšã«ãããã¹ã¿ãã³çæã劚害ã
ãè©Šè¬ã¯ãH1åã³H2å容äœã®åŠšå®³å€ã§ããæã
ã¹ã¿ãã³å€ãšåãæ§ã«æçšã§ãããšå ±åãããŠã
ãããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒæå¶å€ã¯ãæŽ
ã«ãã¹ã¿ãã³å«æéã®é«ãããçš®ã®è «çã®æå¶ã«
ãããŠæçšã§ãããšæ瀺ãããŠããã
ã«ãã¹ããžã³åã³Î±âããã©ãžããã¹ããžã³ã®æŽ»
æ§ãæå¶ããããšã«ãããã¹ã¿ãã³çæã劚害ã
ãè©Šè¬ã¯ãH1åã³H2å容äœã®åŠšå®³å€ã§ããæã
ã¹ã¿ãã³å€ãšåãæ§ã«æçšã§ãããšå ±åãããŠã
ãããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒæå¶å€ã¯ãæŽ
ã«ãã¹ã¿ãã³å«æéã®é«ãããçš®ã®è «çã®æå¶ã«
ãããŠæçšã§ãããšæ瀺ãããŠããã
æ¬çºæã®ååç©ã¯ããã¹ããžã³ãã«ã«ããã·ã©
ãŒãŒã®æŽ»æ§ãæå¶ããããããšã«ãããã¹ã¿ãã³
ã®çæã劚害ããããã該ååç©ã¯ãã¹ã¿ãã³ã«
ããçããç çççåŠçç¶æ ã®æ²»çã«ãããŠæçš
ã§ãããæ¬çºæã®ç¹èš±è«æ±ã®ç¯å²ã«èšãããŠãã
ååç©ã¯ãH1åã³H2å容äœã«æããååç©ãšå
ãæ¹æ³ã§ãããŠåãç®ççšã«äœ¿çšã§ããã
ãŒãŒã®æŽ»æ§ãæå¶ããããããšã«ãããã¹ã¿ãã³
ã®çæã劚害ããããã該ååç©ã¯ãã¹ã¿ãã³ã«
ããçããç çççåŠçç¶æ ã®æ²»çã«ãããŠæçš
ã§ãããæ¬çºæã®ç¹èš±è«æ±ã®ç¯å²ã«èšãããŠãã
ååç©ã¯ãH1åã³H2å容äœã«æããååç©ãšå
ãæ¹æ³ã§ãããŠåãç®ççšã«äœ¿çšã§ããã
æ¬çºæã®ååç©ã¯ãäžèšã®äžè¬åŒã«ããè¡šã
ãããïŒ äžèšã®äžè¬åŒã«ãããŠãã¯F2CHâåã¯
F3Câã§ããã
ãããïŒ äžèšã®äžè¬åŒã«ãããŠãã¯F2CHâåã¯
F3Câã§ããã
äžè¬åŒã®ååç©ã®è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©é¡
åã³åå åŠçç°æ§äœé¡ãæ¬çºæã®ç¯å²å ã«å å«ã
ããã
åã³åå åŠçç°æ§äœé¡ãæ¬çºæã®ç¯å²å ã«å å«ã
ããã
æ¬èæ¡ã®ååç©ã®è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©é¡ã®
代衚äŸã«ã¯ãç¡æ©é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žã
ç¡«é žåã³ãªã³é žäžŠã³ã«ææ©é žãäŸãã°ã¡ã¿ã³ã¹ã«
ãã³é žããµãªãã«é žããã¬ã€ã³é žãã·ã¯ã©ããã¯
ã¢ã·ããïŒã·ã¯ããããµã³ã¹ã«ãã¢ãã³é žïŒãã
ã³é žãé ç³é žããããé žåã³ã¢ã¹ã³ã«ãã³é žãçš
ããŠè£œé ãããéæ¯æ§é žä»å å¡©ãå«ãŸãããå¡©é¡
ã¯äžè¬çæ¹æ³ã«ãã補é ãããã
代衚äŸã«ã¯ãç¡æ©é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žã
ç¡«é žåã³ãªã³é žäžŠã³ã«ææ©é žãäŸãã°ã¡ã¿ã³ã¹ã«
ãã³é žããµãªãã«é žããã¬ã€ã³é žãã·ã¯ã©ããã¯
ã¢ã·ããïŒã·ã¯ããããµã³ã¹ã«ãã¢ãã³é žïŒãã
ã³é žãé ç³é žããããé žåã³ã¢ã¹ã³ã«ãã³é žãçš
ããŠè£œé ãããéæ¯æ§é žä»å å¡©ãå«ãŸãããå¡©é¡
ã¯äžè¬çæ¹æ³ã«ãã補é ãããã
åŒã®ååç©ã¯çäœå
ã§ãã¹ããžã³ããã¹ã¿ã
ã³ã«è»¢åããããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒé µ
çŽ ã®éå¯éçæå¶å€ã§ãããåŸã€ãŠè©²ååç©ã¯ã
ããçš®ã®ç çççåŠç¶æ ã«ãããŠé倧ãªåœ¹å²ãã
ãŠããããšãç¥ãããŠãããã¹ã¿ãã³ã®çæã劚
害ããããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€
ãšããŠæ¬çºæã®ååç©ã¯ãH1ãããã¯H2å容äœ
ã劚害ããããšã«ããåã¯ä»ã®æ段ã«ããå¹æã
äžããå ¬ç¥ã®æãã¹ã¿ãã³å€ãšåæ§ã«æçšã§ã
ããæ¬çºæã®ååç©ã¯ãã¹ã¿ãã³ãåå ã§ããç
çççåŠç¶æ ã®æ²»çã«æçšã§ãããåŸã€ãŠãäžè¬
åŒã®ååç©ã¯æ¥æ§ã®æ»²åºæ§åã®ã¢ã¬ã«ã®ãŒãäŸ
ãã°å£ç¯ç錻çãæ¯èç±åã³è±ç²çã®æ²»çã«ãã
ãŠããããã¿ã錻æŒãç®ã錻ãã®ã©ã®ããã¿ã軜
æžããããã®å€ãã®çšéãæããŠãããäžè¬åŒ
ã®ååç©ã¯ãå³ã®å¶åŸ¡ã«ãããŠãããŠå šèº«çéæ
çåã³æ°ç®¡æ¯åæ¯ã®æ²»çã«ãããŠãæçšã§ããã
ãããŠæ°ç®¡æ¯æ¡åŒµå€ãšããŠæçšã§ããããŸããäž
è¬åŒã®ååç©ã¯ã¢ã¬ã«ã®ãŒæ§ç®èç ãäŸãã°æ¥
æ§ãããŸãããæ ¢æ§ãããŸãããè¡ç®¡æµ®è «ãç
çãäŸãã°éææ§ç®èçåã³æ¥è§Šç®èçã®æ²»çã«
ãããŠæçšã§ãããäžè¬åŒã®ååç©ã¯è¡æž çŸç
ã®ãããŸããåã³æµ®è «ç å€ãã¢ã¬ã«ã®ãŒçŸè±¡ã«ã
ã茞è¡åå¿åã³æªå¿ã®æ²»çã«ãããŠãæçšã§ã
ããäžè¬åŒã®ååç©ã¯æ¶ååšæœ°ç圢æããŸãªã³
ã²ã«âãšãªãœã³çå矀åã³ä»ã®è液åæ³éå€çã®
æ²»çã«ãããŠãæçšã§ãããäžèšã®åŠãããã¹ã¿
ãã³æ°Žæºã¯æ¥éæé·ããçµç¹ãäŸãã°è «çäžã§é«
ãããšãèŠåºãããŠãããããäžè¬åŒã®ååç©
ã¯ãã¹ã¿ãã³ã®çæãæå¶ããããšã«ããããçš®
ã®è «çãäŸãã°ãŠãªãŒã«ãŒæµ®çåã³ãšã«ãªããè ¹
æ°Žè «çã®æé·æå¶ã«ãããŠæçšã§ããåŸãã
ã³ã«è»¢åããããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒé µ
çŽ ã®éå¯éçæå¶å€ã§ãããåŸã€ãŠè©²ååç©ã¯ã
ããçš®ã®ç çççåŠç¶æ ã«ãããŠé倧ãªåœ¹å²ãã
ãŠããããšãç¥ãããŠãããã¹ã¿ãã³ã®çæã劚
害ããããã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®æå¶å€
ãšããŠæ¬çºæã®ååç©ã¯ãH1ãããã¯H2å容äœ
ã劚害ããããšã«ããåã¯ä»ã®æ段ã«ããå¹æã
äžããå ¬ç¥ã®æãã¹ã¿ãã³å€ãšåæ§ã«æçšã§ã
ããæ¬çºæã®ååç©ã¯ãã¹ã¿ãã³ãåå ã§ããç
çççåŠç¶æ ã®æ²»çã«æçšã§ãããåŸã€ãŠãäžè¬
åŒã®ååç©ã¯æ¥æ§ã®æ»²åºæ§åã®ã¢ã¬ã«ã®ãŒãäŸ
ãã°å£ç¯ç錻çãæ¯èç±åã³è±ç²çã®æ²»çã«ãã
ãŠããããã¿ã錻æŒãç®ã錻ãã®ã©ã®ããã¿ã軜
æžããããã®å€ãã®çšéãæããŠãããäžè¬åŒ
ã®ååç©ã¯ãå³ã®å¶åŸ¡ã«ãããŠãããŠå šèº«çéæ
çåã³æ°ç®¡æ¯åæ¯ã®æ²»çã«ãããŠãæçšã§ããã
ãããŠæ°ç®¡æ¯æ¡åŒµå€ãšããŠæçšã§ããããŸããäž
è¬åŒã®ååç©ã¯ã¢ã¬ã«ã®ãŒæ§ç®èç ãäŸãã°æ¥
æ§ãããŸãããæ ¢æ§ãããŸãããè¡ç®¡æµ®è «ãç
çãäŸãã°éææ§ç®èçåã³æ¥è§Šç®èçã®æ²»çã«
ãããŠæçšã§ãããäžè¬åŒã®ååç©ã¯è¡æž çŸç
ã®ãããŸããåã³æµ®è «ç å€ãã¢ã¬ã«ã®ãŒçŸè±¡ã«ã
ã茞è¡åå¿åã³æªå¿ã®æ²»çã«ãããŠãæçšã§ã
ããäžè¬åŒã®ååç©ã¯æ¶ååšæœ°ç圢æããŸãªã³
ã²ã«âãšãªãœã³çå矀åã³ä»ã®è液åæ³éå€çã®
æ²»çã«ãããŠãæçšã§ãããäžèšã®åŠãããã¹ã¿
ãã³æ°Žæºã¯æ¥éæé·ããçµç¹ãäŸãã°è «çäžã§é«
ãããšãèŠåºãããŠãããããäžè¬åŒã®ååç©
ã¯ãã¹ã¿ãã³ã®çæãæå¶ããããšã«ããããçš®
ã®è «çãäŸãã°ãŠãªãŒã«ãŒæµ®çåã³ãšã«ãªããè ¹
æ°Žè «çã®æé·æå¶ã«ãããŠæçšã§ããåŸãã
æ¬çºæã®ååç©ãçš®ã
ã®æ¹æ³ã§æäžããŠåžæã
ãå¹æãåŸãããšãã§ãããååç©ãåç¬ã§åã¯
補è¬èª¿å€ã®åœ¢ã§ãæ²»çããããšããæ£è ã«çµå£ç
ã«ãéçµå£çã«ããªãã¡ç®äžã«ãéèå ã«ããã
ã¯è ¹è å ã«ãåã¯å±éšçã«æäžã§ãããååç©ã¯
錻å ç¹æ»Žæ³šå ¥æ³ã«ããåã¯ç²èäŸãã°éŒ»ãã®ã©å
ã³æ°ç®¡æ¯ç®¡ã®ç²èã«ãäŸãã°ã¹ãã¬ãŒæº¶æ¶²äžã«æ¬
çºæã®æ°èŠååç©ã®å°ç²åãå«æããŠãããšãŒã
ãŸã«ã¹ãã¬ãŒåœ¢åã¯ä¹Ÿç¥ç²æ«åœ¢ã§æäžããããšã
ã§ããã
ãå¹æãåŸãããšãã§ãããååç©ãåç¬ã§åã¯
補è¬èª¿å€ã®åœ¢ã§ãæ²»çããããšããæ£è ã«çµå£ç
ã«ãéçµå£çã«ããªãã¡ç®äžã«ãéèå ã«ããã
ã¯è ¹è å ã«ãåã¯å±éšçã«æäžã§ãããååç©ã¯
錻å ç¹æ»Žæ³šå ¥æ³ã«ããåã¯ç²èäŸãã°éŒ»ãã®ã©å
ã³æ°ç®¡æ¯ç®¡ã®ç²èã«ãäŸãã°ã¹ãã¬ãŒæº¶æ¶²äžã«æ¬
çºæã®æ°èŠååç©ã®å°ç²åãå«æããŠãããšãŒã
ãŸã«ã¹ãã¬ãŒåœ¢åã¯ä¹Ÿç¥ç²æ«åœ¢ã§æäžããããšã
ã§ããã
æ°èŠååç©ã®æäžéã¯å€åããä»»æã®æå¹éã§
ãããæ£è ãæ²»çãããçç¶ãæäžåœ¢æ ã«ããã
æ°èŠååç©ã®æäžéã¯åºãç¯å²å ã«ããã€ãŠå€å
ããããšãã§ããïŒæäžéåœãçŽ0.1ã500mgïŒ
ïŒïŒKgã®æ£è ã®äœéïŒåã³å¥œé©ã«ã¯çŽ50ã200mgïŒ
ïŒïŒKgã®æ£è ã®äœéïŒã®åäœé©é圢ã®æå¹éãäž
ãããäŸãã°ãïŒæ¥ã«ïŒãïŒåæäžããã10ã
500mgã®æ¬çºæã®æ°èŠãªååç©ãå«æããŠããé
å€ã®åŠãåäœé©é圢ã®æåã«ããåžæããå¹æã
åŸãããã
ãããæ£è ãæ²»çãããçç¶ãæäžåœ¢æ ã«ããã
æ°èŠååç©ã®æäžéã¯åºãç¯å²å ã«ããã€ãŠå€å
ããããšãã§ããïŒæäžéåœãçŽ0.1ã500mgïŒ
ïŒïŒKgã®æ£è ã®äœéïŒåã³å¥œé©ã«ã¯çŽ50ã200mgïŒ
ïŒïŒKgã®æ£è ã®äœéïŒã®åäœé©é圢ã®æå¹éãäž
ãããäŸãã°ãïŒæ¥ã«ïŒãïŒåæäžããã10ã
500mgã®æ¬çºæã®æ°èŠãªååç©ãå«æããŠããé
å€ã®åŠãåäœé©é圢ã®æåã«ããåžæããå¹æã
åŸãããã
ããã§äœ¿çšãããŠãããæ£è
ããšããèªã¯æž©è¡
åç©ãäŸãã°é³¥åã³åºä¹³åç©ãäŸãã°ãããç¬ã
ããã¿ãã¯ã€ãããã¿ãã¢ã«ã¢ãããçŸã銬ãç
åã³äººéãæå³ããã
åç©ãäŸãã°é³¥åã³åºä¹³åç©ãäŸãã°ãããç¬ã
ããã¿ãã¯ã€ãããã¿ãã¢ã«ã¢ãããçŸã銬ãç
åã³äººéãæå³ããã
åºäœã®åäœé©é圢ã¯äžè¬çãªåã§ããããšãã§
ãããåŸã€ãŠãåºäœåœ¢ã¯æ¬çºæã®æ°èŠååç©åã³
æ äœãäŸãã°æœ€æ»å€åã³äžæŽ»æ§å ãŠãå€äŸãã°ä¹³
ç³ã庶ç³åã³ã³ãŒã³ã¹ã¿ãŒããå«æããŠããæ®é
ã®ãŒã©ãã³åã®ã«ãã»ã«ã§ããåŸããä»ã®æ æ§ã«
ãããŠã¯ãæ°èŠååç©ãäžè¬çé å€ããŒã¹ãäŸã
ã°ä¹³ç³ã庶ç³åã¯ã³ãŒã³ã¹ã¿ãŒããçµåå€äŸãã°
ã¢ã©ãã¢ãŽã ãã³ãŒã³ã¹ã¿ãŒããããã¯ãŒã©ã
ã³ã厩å£å€ãäŸãã°ã³ãŒã³ã¹ã¿ãŒããã°ãããã
ã§ãã·ããããã¯ã¢ã«ã®ã³é žåã³æœ€æ»å€äŸãã°ã¹
ãã¢ãªã³é žãããã¯ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãš
äžç·ã«ãé å€åããã
ãããåŸã€ãŠãåºäœåœ¢ã¯æ¬çºæã®æ°èŠååç©åã³
æ äœãäŸãã°æœ€æ»å€åã³äžæŽ»æ§å ãŠãå€äŸãã°ä¹³
ç³ã庶ç³åã³ã³ãŒã³ã¹ã¿ãŒããå«æããŠããæ®é
ã®ãŒã©ãã³åã®ã«ãã»ã«ã§ããåŸããä»ã®æ æ§ã«
ãããŠã¯ãæ°èŠååç©ãäžè¬çé å€ããŒã¹ãäŸã
ã°ä¹³ç³ã庶ç³åã¯ã³ãŒã³ã¹ã¿ãŒããçµåå€äŸãã°
ã¢ã©ãã¢ãŽã ãã³ãŒã³ã¹ã¿ãŒããããã¯ãŒã©ã
ã³ã厩å£å€ãäŸãã°ã³ãŒã³ã¹ã¿ãŒããã°ãããã
ã§ãã·ããããã¯ã¢ã«ã®ã³é žåã³æœ€æ»å€äŸãã°ã¹
ãã¢ãªã³é žãããã¯ã¹ãã¢ãªã³é žãã°ãã·ãŠã ãš
äžç·ã«ãé å€åããã
éçµå£çæäžçšã«ããå Žåã«ã¯ãççåŠçã«èš±
容å¯èœãªåžéå€äžã«ååç©ãäŸãã°æ°Žåã³æ²¹ã®åŠ
ãæžè液ã§ãã補è¬æ äœãšå ±ã«ãè¡šé¢æŽ»æ§å€åã³
ä»ã®è£œè¬åŠçã«èš±å®¹å¯èœãªäœè¬ãæ·»å ããŠåã¯æ·»
å ããã«ãå«æããŠãã溶液åã¯æžæ¿æ¶²ã®æ³šå°æ
äžç©ãšããŠæäžããããšãã§ããããããã®èª¿å€
äžã§äœ¿çšã§ããæ²¹ã®ä»£è¡šäŸã¯ãç³æ²¹ãåç©ãæ€ç©
åã¯åææºã®ãã®ãäŸãã°å京è±æ²¹ã倧è±æ²¹åã³
é±æ²¹ã§ãããäžè¬ã«ãæ°Žãé£å¡©æ°Žãæ°Žæ§ããã¹ã
ããŒã¹åã³é¢é£ç³æº¶æ¶²ããšã¿ããŒã«åã³ã°ãªã³ãŒ
ã«ãäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã¯ããªãšãã¬
ã³ã°ãªã³ãŒã«ããç¹ã«æ³šå°æº¶æ¶²ãšããŠå¥œé©ãªæ¶²äœ
æ äœã§ããã
容å¯èœãªåžéå€äžã«ååç©ãäŸãã°æ°Žåã³æ²¹ã®åŠ
ãæžè液ã§ãã補è¬æ äœãšå ±ã«ãè¡šé¢æŽ»æ§å€åã³
ä»ã®è£œè¬åŠçã«èš±å®¹å¯èœãªäœè¬ãæ·»å ããŠåã¯æ·»
å ããã«ãå«æããŠãã溶液åã¯æžæ¿æ¶²ã®æ³šå°æ
äžç©ãšããŠæäžããããšãã§ããããããã®èª¿å€
äžã§äœ¿çšã§ããæ²¹ã®ä»£è¡šäŸã¯ãç³æ²¹ãåç©ãæ€ç©
åã¯åææºã®ãã®ãäŸãã°å京è±æ²¹ã倧è±æ²¹åã³
é±æ²¹ã§ãããäžè¬ã«ãæ°Žãé£å¡©æ°Žãæ°Žæ§ããã¹ã
ããŒã¹åã³é¢é£ç³æº¶æ¶²ããšã¿ããŒã«åã³ã°ãªã³ãŒ
ã«ãäŸãã°ãããã¬ã³ã°ãªã³ãŒã«åã¯ããªãšãã¬
ã³ã°ãªã³ãŒã«ããç¹ã«æ³šå°æº¶æ¶²ãšããŠå¥œé©ãªæ¶²äœ
æ äœã§ããã
ååç©ã¯æŽ»æ§æåãæç¶æŸåºããããããªæ¹æ³
ã«èª¿åãããããŒæ³šå°å€åã¯ç§»æ€èª¿å€ã®åœ¢ã§æäž
ããããšãã§ããã掻æ§æåããã¬ããåã¯å°å
ç圢ã«å§çž®ã§ããããŠãããŒæ³šå°å€åã¯ç§»æ€ç©ãš
ããŠç®äžã«åã¯çèå ã«ç§»æ€ãããã移æ€ç©ã¯äž
掻æ§ç©è³ªãäŸãã°çäœå å解å¯èœéåäœåã¯åæ
ã·ãªã³ãŒã³ãäŸãã°ããŠâã³ãŠãã³ã°ã»ã³ãŒãã¬
ãŒã·ãšã³è£œã·ãªã³ãŒã³ãŽã ã§ããã·ã©ã¹ããã¯
ïŒSilasticïŒã§ããã
ã«èª¿åãããããŒæ³šå°å€åã¯ç§»æ€èª¿å€ã®åœ¢ã§æäž
ããããšãã§ããã掻æ§æåããã¬ããåã¯å°å
ç圢ã«å§çž®ã§ããããŠãããŒæ³šå°å€åã¯ç§»æ€ç©ãš
ããŠç®äžã«åã¯çèå ã«ç§»æ€ãããã移æ€ç©ã¯äž
掻æ§ç©è³ªãäŸãã°çäœå å解å¯èœéåäœåã¯åæ
ã·ãªã³ãŒã³ãäŸãã°ããŠâã³ãŠãã³ã°ã»ã³ãŒãã¬
ãŒã·ãšã³è£œã·ãªã³ãŒã³ãŽã ã§ããã·ã©ã¹ããã¯
ïŒSilasticïŒã§ããã
ãšãŒããŸã«ãšããŠã®äœ¿çšããããã«ã¯ã溶液å
ã¯æžæ¿æ¶²ç¶ã®æ°èŠãªååç©ãå å§ããããšãŒããŸ
ã«å®¹åšäžã«æ°äœãããã¯æ¶²åãããæ å°å€ãäŸã
ã°ãžã¯ãããžãã«ãªãã¡ã¿ã³ããžã¯ãããžãã«ãª
ãã¡ã¿ã³åã³ãžã¯ãããžãã«ãªããšã¿ã³ãäºé žå
ççŽ ãçªçŽ åã¯ãããã³ãšäžç·ã«å å¡«ã§ãããã®
éå¿ èŠã«ããåã¯åžæã«ããæ®éã«ããå ±æº¶åªå
ã³æ¹¿æœ€å€ã䜿çšãããååç©ãå å§ãããŠããªã
圢ã§ãäŸãã°ç é§åšåã¯åŽé§åšã§ãæäžããããš
ãã§ããã
ã¯æžæ¿æ¶²ç¶ã®æ°èŠãªååç©ãå å§ããããšãŒããŸ
ã«å®¹åšäžã«æ°äœãããã¯æ¶²åãããæ å°å€ãäŸã
ã°ãžã¯ãããžãã«ãªãã¡ã¿ã³ããžã¯ãããžãã«ãª
ãã¡ã¿ã³åã³ãžã¯ãããžãã«ãªããšã¿ã³ãäºé žå
ççŽ ãçªçŽ åã¯ãããã³ãšäžç·ã«å å¡«ã§ãããã®
éå¿ èŠã«ããåã¯åžæã«ããæ®éã«ããå ±æº¶åªå
ã³æ¹¿æœ€å€ã䜿çšãããååç©ãå å§ãããŠããªã
圢ã§ãäŸãã°ç é§åšåã¯åŽé§åšã§ãæäžããããš
ãã§ããã
ãã¹ããžã³ãã«ã«ããã·ã©ãŒãŒã®éå¯éçæå¶
å€ãšããŠã®äžè¬åŒã®ååç©ã®å©çšã以äžã«ç€º
ããäžè¬åŒã®ååç©ã氎溶液ãããã¯æžæ¿å€ã
ããã¿åã¯ã¯ã€ãããã¿ã«çµå£çãããã¯éçµå£
çã«æäžãããè©Šéšååç©ã®æäžåŸã«ç°ãªãæé
ééã«ãããŠãåç©ã®è ¹è å ã«ïŒÎŒCiã®ïŒâ14C
ââãã¹ããžã³ã泚å°ãããã©ãã«ããããã¹
ããžã³ã®æ³šå°ã®ïŒæéåŸã«åç©ã殺ãããããŠè
ã®å°è ºéšåäžã«ååšããŠããæŸå°æ§ãã¹ã¿ãã³é
ãK.M.ã¢ãŒã«ïŒMoleïŒåã³D.M.ã·ãšãã¢ãŒã
ïŒShepherdïŒã®J.Pharm.Pharmac.25ïŒ609ã613
ïŒ1973ïŒã«èšãããŠããåŠãããŠæž¬å®ããã
å€ãšããŠã®äžè¬åŒã®ååç©ã®å©çšã以äžã«ç€º
ããäžè¬åŒã®ååç©ã氎溶液ãããã¯æžæ¿å€ã
ããã¿åã¯ã¯ã€ãããã¿ã«çµå£çãããã¯éçµå£
çã«æäžãããè©Šéšååç©ã®æäžåŸã«ç°ãªãæé
ééã«ãããŠãåç©ã®è ¹è å ã«ïŒÎŒCiã®ïŒâ14C
ââãã¹ããžã³ã泚å°ãããã©ãã«ããããã¹
ããžã³ã®æ³šå°ã®ïŒæéåŸã«åç©ã殺ãããããŠè
ã®å°è ºéšåäžã«ååšããŠããæŸå°æ§ãã¹ã¿ãã³é
ãK.M.ã¢ãŒã«ïŒMoleïŒåã³D.M.ã·ãšãã¢ãŒã
ïŒShepherdïŒã®J.Pharm.Pharmac.25ïŒ609ã613
ïŒ1973ïŒã«èšãããŠããåŠãããŠæž¬å®ããã
æ¬çºæã®ååç©ã¯ãæçšãªè¬å€ã§ããä»ã«ãæ
çç©è³ªãšããŠæçšãªäžèšäžè¬åŒã®ã»ãã¢ãã¹ã
ãªã³èªå°äœã®è£œé çšã®äžéçæç©ãšããŠãæçšã§
ããïŒ äžèšã®äžè¬åŒã«ãããŠãã¯æ°ŽçŽ ãã¢ã»ãã
ã·ã§ããïŒïŒã¯æ°ŽçŽ åã¯è² é»è·ã§ããïŒR1åã³
R2ã¯æ°ŽçŽ ã§ããã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããã
çç©è³ªãšããŠæçšãªäžèšäžè¬åŒã®ã»ãã¢ãã¹ã
ãªã³èªå°äœã®è£œé çšã®äžéçæç©ãšããŠãæçšã§
ããïŒ äžèšã®äžè¬åŒã«ãããŠãã¯æ°ŽçŽ ãã¢ã»ãã
ã·ã§ããïŒïŒã¯æ°ŽçŽ åã¯è² é»è·ã§ããïŒR1åã³
R2ã¯æ°ŽçŽ ã§ããã¯äžè¬åŒã§å®çŸ©ãããŠãã
æå³ãæããã
äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬åŠçã«èš±
容å¯èœãªå¡©é¡åã³åå åŠç°æ§äœã¯æçç©è³ªãšããŠ
æçšãªæ°èŠãªååç©ã§ããããããŠå€ãã®å ¬ç¥ã®
ã»ãã¢ãã¹ããªã³èªå°äœãäŸãã°ã»ãã¢ã¬ãã·
ã³ãã»ãã¢ããã³ãåã¯ã»ãã¢ãã°ãªã·ã³ã®æäž
æ¹æ³ãšåæ§ãªæ¹æ³ã§æäžã§ãããäžè¬åŒã®åå
ç©äžŠã³ã«è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©é¡åã³ç°æ§äœã
åç¬ã§åã¯è£œè¬èª¿å€ã®åœ¢ã§çµå£çåã¯éçµå£çã«
ãããŠå±éšçã«æž©è¡åç©ãããªãã¡é³¥åã³åºä¹³å
ç©ãäŸãã°ç«ãç¬ãçãçŸã銬åã³äººéã«æäžã§
ãããçµå£çæäžçšã«ã¯ãååç©ãé å€ãã«ãã»
ã«ãããã¯äžžè¬ã®åœ¢ã§ãåã¯ãšãªãã·ã«ãããã¯
æžæ¿æ¶²ã®åœ¢ã§æäžã§ãããéçµå£çæäžçšã«ã¯ã
ååç©ã¯ä»ã®æº¶è³ªãäŸãã°æº¶æ¶²ãç匵æ§ã«ããã®
ã«å åãªé£å¡©æ°Žåã¯ã°ã«ã³ãŒã¹ãå«æããŠããŠã
ããæžæ®ºè氎溶液ã®åœ¢ã§æè¯ã«äœ¿çšã§ãããå±éš
çæäžçšã«ã¯ãäžè¬åŒã®ååç©ããããã®å¡©é¡
åã³ç°æ§äœãã¯ãªãŒã åã¯è»èäžã«å ããã
容å¯èœãªå¡©é¡åã³åå åŠç°æ§äœã¯æçç©è³ªãšããŠ
æçšãªæ°èŠãªååç©ã§ããããããŠå€ãã®å ¬ç¥ã®
ã»ãã¢ãã¹ããªã³èªå°äœãäŸãã°ã»ãã¢ã¬ãã·
ã³ãã»ãã¢ããã³ãåã¯ã»ãã¢ãã°ãªã·ã³ã®æäž
æ¹æ³ãšåæ§ãªæ¹æ³ã§æäžã§ãããäžè¬åŒã®åå
ç©äžŠã³ã«è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©é¡åã³ç°æ§äœã
åç¬ã§åã¯è£œè¬èª¿å€ã®åœ¢ã§çµå£çåã¯éçµå£çã«
ãããŠå±éšçã«æž©è¡åç©ãããªãã¡é³¥åã³åºä¹³å
ç©ãäŸãã°ç«ãç¬ãçãçŸã銬åã³äººéã«æäžã§
ãããçµå£çæäžçšã«ã¯ãååç©ãé å€ãã«ãã»
ã«ãããã¯äžžè¬ã®åœ¢ã§ãåã¯ãšãªãã·ã«ãããã¯
æžæ¿æ¶²ã®åœ¢ã§æäžã§ãããéçµå£çæäžçšã«ã¯ã
ååç©ã¯ä»ã®æº¶è³ªãäŸãã°æº¶æ¶²ãç匵æ§ã«ããã®
ã«å åãªé£å¡©æ°Žåã¯ã°ã«ã³ãŒã¹ãå«æããŠããŠã
ããæžæ®ºè氎溶液ã®åœ¢ã§æè¯ã«äœ¿çšã§ãããå±éš
çæäžçšã«ã¯ãäžè¬åŒã®ååç©ããããã®å¡©é¡
åã³ç°æ§äœãã¯ãªãŒã åã¯è»èäžã«å ããã
äžè¬åŒã®ååç©äžŠã³ã«ãããã®è£œè¬åŠçã«èš±
容å¯èœãªå¡©åã³åå åŠçç°æ§äœãããã«å¯ŸããŠæŽ»
æ§ãªçŽ°èã®ä»£è¡šäŸã¯ãé»è²è¡èçèããã©ããã¹
èãèºçèèãèºçåèçåã³åè¿é£éçèã§
ããã
容å¯èœãªå¡©åã³åå åŠçç°æ§äœãããã«å¯ŸããŠæŽ»
æ§ãªçŽ°èã®ä»£è¡šäŸã¯ãé»è²è¡èçèããã©ããã¹
èãèºçèèãèºçåèçåã³åè¿é£éçèã§
ããã
äžè¬åŒã®ååç©ã®ä»£è¡šçãªè£œè¬åŠçã«èš±å®¹å¯
èœãªéæ¯æ§ç¡æ©é žä»å å¡©é¡ã¯ãé±é žä»å å¡©é¡ãäŸ
ãã°å¡©é žå¡©ãèåæ°ŽçŽ å¡©ãç¡«é žå¡©ãã¹ã«ãã¢ãã³
é žå¡©ããªã³é žå¡©ã§ããããããŠææ©é žä»å å¡©ã¯äŸ
ãã°ãã¬ã€ã³é žå¡©ãé ¢é žå¡©ããããé žå¡©ãããã
é žå¡©ããã¯ãé žå¡©ãå®æ¯éŠé žå¡©ãé ç³é žå¡©ããã
ãŒã«é žå¡©ããªã³ãŽé žå¡©åã³ã¢ã¹ã³ã«ãã³é žå¡©ã§ã
ããå¡©é¡ã¯äžè¬çæ¹æ³ã«ãã補é ã§ããã
èœãªéæ¯æ§ç¡æ©é žä»å å¡©é¡ã¯ãé±é žä»å å¡©é¡ãäŸ
ãã°å¡©é žå¡©ãèåæ°ŽçŽ å¡©ãç¡«é žå¡©ãã¹ã«ãã¢ãã³
é žå¡©ããªã³é žå¡©ã§ããããããŠææ©é žä»å å¡©ã¯äŸ
ãã°ãã¬ã€ã³é žå¡©ãé ¢é žå¡©ããããé žå¡©ãããã
é žå¡©ããã¯ãé žå¡©ãå®æ¯éŠé žå¡©ãé ç³é žå¡©ããã
ãŒã«é žå¡©ããªã³ãŽé žå¡©åã³ã¢ã¹ã³ã«ãã³é žå¡©ã§ã
ããå¡©é¡ã¯äžè¬çæ¹æ³ã«ãã補é ã§ããã
äžè¬åŒã®ååç©ã¯ãããã§ã¯åç
§ãšããŠèšã
ç±³åœç¹èš±ç¬¬3919206å·ã«èšãããŠããåŠãæ¹æ³ã§
補é ãããåŒ ãåŒäžãåã³ïŒã¯äžè¬åŒã«å®çŸ©ãããŠãã
æå³ãæããã ã®ååç©ããäžè¬åŒïŒã®ååç©ãšåå¿ãããããš
ã«ãã補é ããããåå¿ã¯äžè¬ã«æº¶åªãäŸãã°äœ
çŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ã
ããã¯ã€ãœãããã«ã¢ã«ã³ãŒã«ãåã¯ãžã¡ãã«ã¹
ã«ããã·ãããžã¡ãã«ãã«ã ã¢ããæãã¯ããã
ã®æº¶åªã®æ°Žæ§æ··åç©äžã§å®æœããããåå¿æž©åºŠã¯
çŽïŒãã125âã®éã§å€åã§ãããããŠåå¿æé
ã¯çŽ1/2æéã24æéã®éã§å€åã§ãããå 溶åª
å解åŸã«ãã¢ããä¿è·åºãé žå æ°Žå解ã«ããé€
ãããããŠã»ãã¢ãã¹ããªã³çæç©ãäžè¬çæ¹æ³
ã«ããåé¢ããã
ç±³åœç¹èš±ç¬¬3919206å·ã«èšãããŠããåŠãæ¹æ³ã§
補é ãããåŒ ãåŒäžãåã³ïŒã¯äžè¬åŒã«å®çŸ©ãããŠãã
æå³ãæããã ã®ååç©ããäžè¬åŒïŒã®ååç©ãšåå¿ãããããš
ã«ãã補é ããããåå¿ã¯äžè¬ã«æº¶åªãäŸãã°äœ
çŽã¢ã«ã³ãŒã«ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ã
ããã¯ã€ãœãããã«ã¢ã«ã³ãŒã«ãåã¯ãžã¡ãã«ã¹
ã«ããã·ãããžã¡ãã«ãã«ã ã¢ããæãã¯ããã
ã®æº¶åªã®æ°Žæ§æ··åç©äžã§å®æœããããåå¿æž©åºŠã¯
çŽïŒãã125âã®éã§å€åã§ãããããŠåå¿æé
ã¯çŽ1/2æéã24æéã®éã§å€åã§ãããå 溶åª
å解åŸã«ãã¢ããä¿è·åºãé žå æ°Žå解ã«ããé€
ãããããŠã»ãã¢ãã¹ããªã³çæç©ãäžè¬çæ¹æ³
ã«ããåé¢ããã
ãæ°ŽçŽ ã§ããäžè¬åŒã®ååç©ã¯ãäžèšã®åŒ
ã«ããèšãããŠããåŠãé©åœã«çœ®æãããïŒâ
ã€ãããŸãªã«ããã¡ãã«ã±ãã³èªå°äœã察å¿ãã
ã¢ã«ã³ãŒã«ã«éå ããããã溶åªãäŸãã°ãšãŒã
ã«é¡ãäŸãã°ãžãšãã«ãšãŒãã«ãããã©ãããã
ã©ã³ãããã¯ïœâãžãªããµã³ããã³ãŒã³åã¯ãžã¡
ããã·ãšã¿ã³äžã§ãçŽïŒãã100âã奜é©ã«ã¯çŽ
25âã«ãããŠãçŽ1/2æéã24æéã«ããã€ãŠã
äžæŽ»æ§é°å²æ°äŸãã°çªçŽ åã¯ã¢ã«ãŽã³äžã§ãïŒåœ
éã®ã€ãããäŸãã°ãã¿ã«ã€ããããµã¯ã·ã³ã€ã
ãåã¯ãã¬ã€ã³ã€ããã1.1åœéã®ãã¹ãã€ã³ã
åãã°ããªããšãã«ãã¹ãã€ã³åã¯ããªã¢ã«ãã«
ãã¹ãã€ã³ãäŸãã°ããªâïœâããã«ãã¹ãã€
ã³ãåã³1.1åœéã®ãžãšãã«ã¢ãŸãžã«ã«ããã·ã¬
ãŒãã§åŠçãããããŠãã®ããã«ããŠåŸãããã€
ããèªå°äœãå æ°Žå解ããŠéé¢ã¢ãã³ã«ããããš
ã«ãã補é ãããã
ã«ããèšãããŠããåŠãé©åœã«çœ®æãããïŒâ
ã€ãããŸãªã«ããã¡ãã«ã±ãã³èªå°äœã察å¿ãã
ã¢ã«ã³ãŒã«ã«éå ããããã溶åªãäŸãã°ãšãŒã
ã«é¡ãäŸãã°ãžãšãã«ãšãŒãã«ãããã©ãããã
ã©ã³ãããã¯ïœâãžãªããµã³ããã³ãŒã³åã¯ãžã¡
ããã·ãšã¿ã³äžã§ãçŽïŒãã100âã奜é©ã«ã¯çŽ
25âã«ãããŠãçŽ1/2æéã24æéã«ããã€ãŠã
äžæŽ»æ§é°å²æ°äŸãã°çªçŽ åã¯ã¢ã«ãŽã³äžã§ãïŒåœ
éã®ã€ãããäŸãã°ãã¿ã«ã€ããããµã¯ã·ã³ã€ã
ãåã¯ãã¬ã€ã³ã€ããã1.1åœéã®ãã¹ãã€ã³ã
åãã°ããªããšãã«ãã¹ãã€ã³åã¯ããªã¢ã«ãã«
ãã¹ãã€ã³ãäŸãã°ããªâïœâããã«ãã¹ãã€
ã³ãåã³1.1åœéã®ãžãšãã«ã¢ãŸãžã«ã«ããã·ã¬
ãŒãã§åŠçãããããŠãã®ããã«ããŠåŸãããã€
ããèªå°äœãå æ°Žå解ããŠéé¢ã¢ãã³ã«ããããš
ã«ãã補é ãããã
äžèšäžè¬åŒã«ãããŠãR1åã³R2ã¯æ°ŽçŽ ã§ã
ãã¯äžè¬åŒã§å®çŸ©ãããŠããæå³ãæããã
ãã¯äžè¬åŒã§å®çŸ©ãããŠããæå³ãæããã
åŒã®ã±ãã³é¡ã®å¯Ÿå¿ããã¢ã«ã³ãŒã«ãžã®éå
ã¯ãäŸãã°ïŒã10åœéã®éå±æ°ŽçŽ åç©éå å€ãäŸ
ãã°æ°ŽçŽ åããŠçŽ ãªããŠã ãæ°ŽçŽ åããŠçŽ ãããª
ãŠã ãã·ã¢ãæ°ŽçŽ åããŠçŽ ãããªãŠã ãããã¯æ°Ž
çŽ åãªããŠã ã¢ã«ãããŠã ããã©ã³åã¯ãžã¡ãã«
ããªãã©ã³ã䜿çšããŠååŠçã«ãæãã¯äŸãã°ã©
ããŒããã±ã«ãããžãŠã ããã©ãžãŠã ãããã¯æš
çåã¯é žåçœéã䜿çšããŠæ¥è§Šçã«å®æœãããã
å šäœçã«ã䜿çšãããéå å€ã«ããããåå¿æé
ã¯çŽ10åã24æéã®éã§å€åãããããŠæž©åºŠã¯çŽ
â40âã100âã®éã§å€åãããååŠçéå æ³ã
䜿çšãããšãã«ã¯ãåå¿æéã¯äžè¬ã«çŽ10åã24
æéã®éã§å€åãã枩床ã¯â40âã65âã®éã§å€
åãããäžè¬åŒã®ååç©ã®ååŠçéå æ³çšã®é©
åœãªæº¶åªã«ã¯ãäœçŽã¢ã«ã³ãŒã«é¡ãäŸãã°ã¡ã¿ã
ãŒã«ãããã¯ãšã¿ããŒã«åã¯ãšãŒãã«é¡ãäŸãã°
ãžãšãã«ãšãŒãã«åã¯ããã©ããããã©ã³ãå«ãŸ
ãããæ¥è§Šéå æ³ã䜿çšãããšãã«ã¯ãåå¿æé
ã¯ïŒæéã24æéã®éã§å€åããåå¿æž©åºŠã¯çŽ25
ãã100âã®éã§å€åãããããŠå§åã¯ïŒã120æ°
å§ã®éã§å€åãããäžè¬åŒã®ååç©ã®æ¥è§Šéå
çšã®é©åœãªæº¶åªã«ã¯ãäœçŽã¢ã«ã³ãŒã«é¡äŸãã°ã¡
ã¿ããŒã«ãããã¯ãšã¿ããŒã«ãé ¢é žãåã¯é ¢é žãš
ãã«ãå«ãŸãããååŠçéå æ³ã奜é©ã§ããã
ã¯ãäŸãã°ïŒã10åœéã®éå±æ°ŽçŽ åç©éå å€ãäŸ
ãã°æ°ŽçŽ åããŠçŽ ãªããŠã ãæ°ŽçŽ åããŠçŽ ãããª
ãŠã ãã·ã¢ãæ°ŽçŽ åããŠçŽ ãããªãŠã ãããã¯æ°Ž
çŽ åãªããŠã ã¢ã«ãããŠã ããã©ã³åã¯ãžã¡ãã«
ããªãã©ã³ã䜿çšããŠååŠçã«ãæãã¯äŸãã°ã©
ããŒããã±ã«ãããžãŠã ããã©ãžãŠã ãããã¯æš
çåã¯é žåçœéã䜿çšããŠæ¥è§Šçã«å®æœãããã
å šäœçã«ã䜿çšãããéå å€ã«ããããåå¿æé
ã¯çŽ10åã24æéã®éã§å€åãããããŠæž©åºŠã¯çŽ
â40âã100âã®éã§å€åãããååŠçéå æ³ã
䜿çšãããšãã«ã¯ãåå¿æéã¯äžè¬ã«çŽ10åã24
æéã®éã§å€åãã枩床ã¯â40âã65âã®éã§å€
åãããäžè¬åŒã®ååç©ã®ååŠçéå æ³çšã®é©
åœãªæº¶åªã«ã¯ãäœçŽã¢ã«ã³ãŒã«é¡ãäŸãã°ã¡ã¿ã
ãŒã«ãããã¯ãšã¿ããŒã«åã¯ãšãŒãã«é¡ãäŸãã°
ãžãšãã«ãšãŒãã«åã¯ããã©ããããã©ã³ãå«ãŸ
ãããæ¥è§Šéå æ³ã䜿çšãããšãã«ã¯ãåå¿æé
ã¯ïŒæéã24æéã®éã§å€åããåå¿æž©åºŠã¯çŽ25
ãã100âã®éã§å€åãããããŠå§åã¯ïŒã120æ°
å§ã®éã§å€åãããäžè¬åŒã®ååç©ã®æ¥è§Šéå
çšã®é©åœãªæº¶åªã«ã¯ãäœçŽã¢ã«ã³ãŒã«é¡äŸãã°ã¡
ã¿ããŒã«ãããã¯ãšã¿ããŒã«ãé ¢é žãåã¯é ¢é žãš
ãã«ãå«ãŸãããååŠçéå æ³ã奜é©ã§ããã
ã¢ãã³ãžã®å æ°Žå解åã³ç°ä¿è·åºã®é€å»ã¯ã匷
é±é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žãããã¯ç¡«é žåã¯
ææ©é žãäŸãã°ãã«ãšã³ã¹ã«ãã³é žãããã¯ããª
ãã«ãªãé ¢é žãéæµæž©åºŠã«æŒãŠæ°Žäžã§çŽïŒã48æ
éã«ããã€ãŠäœ¿çšããŠãæãã¯äŸãã°ïŒãïŒåœé
ã®ããã©ãžã³ãã¡ãã«ããã©ãžã³åã¯ã¡ãã«ã¢ã
ã³ãçŽ25âãéæµæž©åºŠã®éã®æž©åºŠã«ãããŠçŽïŒã
12æéã«ããã€ãŠäœ¿çšãããã®åŸäžèšã®åŠã匷é±
é žãããã¯ææ©é žãçšããŠåŠçããããåã¯é©å®
ä¿è·åºãå æ°ŽçŽ å解ããããšã«ããè¡ãªãããã
é±é žãäŸãã°å¡©é žãèåæ°ŽçŽ é žãããã¯ç¡«é žåã¯
ææ©é žãäŸãã°ãã«ãšã³ã¹ã«ãã³é žãããã¯ããª
ãã«ãªãé ¢é žãéæµæž©åºŠã«æŒãŠæ°Žäžã§çŽïŒã48æ
éã«ããã€ãŠäœ¿çšããŠãæãã¯äŸãã°ïŒãïŒåœé
ã®ããã©ãžã³ãã¡ãã«ããã©ãžã³åã¯ã¡ãã«ã¢ã
ã³ãçŽ25âãéæµæž©åºŠã®éã®æž©åºŠã«ãããŠçŽïŒã
12æéã«ããã€ãŠäœ¿çšãããã®åŸäžèšã®åŠã匷é±
é žãããã¯ææ©é žãçšããŠåŠçããããåã¯é©å®
ä¿è·åºãå æ°ŽçŽ å解ããããšã«ããè¡ãªãããã
äžèšã®åŠããããªâã¢ã«ãã«ãã¹ãã€ã³é¡äŸã
ã°ããªâïœâããã«ãã¹ãã€ã³ãåå¿ã«ãããŠäœ¿
çšã§ããããã¢ã«ãã«ããšããèªã¯ãççŽ æ°ãïŒ
ã10ã®ã¢ã«ãã«åºãæå³ãããããªâã¢ã«ãã«ã
ã¹ãã€ã³ã¯åœæ¥çã§å ¬ç¥ã§ããããæãã¯åœæ¥ç
ã§å ¬ç¥ã®æ¹æ³ã«ããåŸãããã
ã°ããªâïœâããã«ãã¹ãã€ã³ãåå¿ã«ãããŠäœ¿
çšã§ããããã¢ã«ãã«ããšããèªã¯ãççŽ æ°ãïŒ
ã10ã®ã¢ã«ãã«åºãæå³ãããããªâã¢ã«ãã«ã
ã¹ãã€ã³ã¯åœæ¥çã§å ¬ç¥ã§ããããæãã¯åœæ¥ç
ã§å ¬ç¥ã®æ¹æ³ã«ããåŸãããã
ãF2CHâã§ããäžè¬åŒã®ååç©ã¯ã
ããïŒã¡ãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªãã¡ã¿ã³
åã¯ããïŒãšãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªããš
ã¿ã³ãé©åœãªåŒ·å¡©åºã§åŠçãããã®åŸåŒ ãåŒäžãR1åã³R2ã¯åŒã§å®çŸ©ãããŠããæ
å³ãæããã ã®é©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«èªå°
äœã§ã¢ã«ãã«åãããã®ããã«ããŠè£œé ãããé©
åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«çœ®æã¹ã«
ãã€ãã«èªå°äœãé©åœãªåŒ·å¡©åºã§åŠçãã次ã«ã¯
ãããžãã«ãªãã¡ã¿ã³ãããã¢ãžãã«ãªãã¡ã¿ã³
åã³ãžãã«ãªãã¡ã¿ã³ããéžæãããé©åœãªãã
ã¡ãã«ããã¢ã«ãã«åå€ã§ã¢ã«ãã«åãããã®åŸ
æ°Žæ§é žã§å æ°Žå解ããŠãé©åœã«R1ïŒR2眮æãã
ãïŒâã¢ã»ããã·ã¡ãã«ã€ãããŸãŒã«èªå°äœãäž
ãããããå¡©åºäŸãã°çé žãããªãŠã åã¯ææ©ã¢
ãã³ã®ååšäžã§çŽ25âã«ãããŠçŽïŒã20æéã«ã
ãã€ãŠïœâãã«ãšã³ã¹ã«ããã«ãã©ã€ããäŸãã°
ïœâãã«ãšã³ã¹ã«ããã«ã¯ãã©ã€ãã§åŠçããã
ãšã«ãããåŸãããã
ããïŒã¡ãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªãã¡ã¿ã³
åã¯ããïŒãšãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªããš
ã¿ã³ãé©åœãªåŒ·å¡©åºã§åŠçãããã®åŸåŒ ãåŒäžãR1åã³R2ã¯åŒã§å®çŸ©ãããŠããæ
å³ãæããã ã®é©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«èªå°
äœã§ã¢ã«ãã«åãããã®ããã«ããŠè£œé ãããé©
åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«çœ®æã¹ã«
ãã€ãã«èªå°äœãé©åœãªåŒ·å¡©åºã§åŠçãã次ã«ã¯
ãããžãã«ãªãã¡ã¿ã³ãããã¢ãžãã«ãªãã¡ã¿ã³
åã³ãžãã«ãªãã¡ã¿ã³ããéžæãããé©åœãªãã
ã¡ãã«ããã¢ã«ãã«åå€ã§ã¢ã«ãã«åãããã®åŸ
æ°Žæ§é žã§å æ°Žå解ããŠãé©åœã«R1ïŒR2眮æãã
ãïŒâã¢ã»ããã·ã¡ãã«ã€ãããŸãŒã«èªå°äœãäž
ãããããå¡©åºäŸãã°çé žãããªãŠã åã¯ææ©ã¢
ãã³ã®ååšäžã§çŽ25âã«ãããŠçŽïŒã20æéã«ã
ãã€ãŠïœâãã«ãšã³ã¹ã«ããã«ãã©ã€ããäŸãã°
ïœâãã«ãšã³ã¹ã«ããã«ã¯ãã©ã€ãã§åŠçããã
ãšã«ãããåŸãããã
äžèšã®åŠããžãã«ãªãã¡ãã«çœ®æãããã±ãã³
èªå°äœã®è£œé ã§äœ¿çšã§ããé©åœãªåŒ·å¡©åºã¯å žåç
ã«ã¯æ°ŽçŽ åãããªãŠã ããžãªããŠã ã¢ã»ããªãª
ãããªããŠã ãžã€ãœãããã«ã¢ãããããã«ãªã
ãŠã ãã«ãªãŠã ã¿ãŒã·ã€ãªãŒâãããã·ãããã
ãªãŠã ã¿ãŒã·ã€ãªãŒâãããã·ãããªããŠã ã¿ãŒ
ã·ã€ãªãŒâãããã·ããããšãã«ãªããŠã ãã¡ã
ã«ãªããŠã ããããªãŠã ã¢ããããªããŠã ã¢ãã
åã¯æ°ŽçŽ åã«ãªãŠã ã§ããã
èªå°äœã®è£œé ã§äœ¿çšã§ããé©åœãªåŒ·å¡©åºã¯å žåç
ã«ã¯æ°ŽçŽ åãããªãŠã ããžãªããŠã ã¢ã»ããªãª
ãããªããŠã ãžã€ãœãããã«ã¢ãããããã«ãªã
ãŠã ãã«ãªãŠã ã¿ãŒã·ã€ãªãŒâãããã·ãããã
ãªãŠã ã¿ãŒã·ã€ãªãŒâãããã·ãããªããŠã ã¿ãŒ
ã·ã€ãªãŒâãããã·ããããšãã«ãªããŠã ãã¡ã
ã«ãªããŠã ããããªãŠã ã¢ããããªããŠã ã¢ãã
åã¯æ°ŽçŽ åã«ãªãŠã ã§ããã
ãžãã«ãªãã¡ãã«ã±ãã³èªå°äœã®è£œé ã§èšãã
ãŠããã¢ã«ãã«ååå¿ã¯ãé©åœãªæº¶åªäŸãã°ãã
ã©ããããã©ã³ããžãšãã«ãšãŒãã«ããããµã¡ã
ã«ãã¹ãã«ããªã¢ããããžã¡ãã«ã¹ã«ããã·ãã
åã¯ãã³ãŒã³äžã§çŽâ78ãã65âã®æž©åºŠç¯å²ã«ã
ããŠçŽ30åã24æéã«ããã€ãŠå®æœãããããžã
ã«ãªãã¡ãã«ã¢ã«ãã«å段éçšã«å¥œé©ãªæž©åºŠã¯çŽ
40âã§ãããã¢ã«ãã«åãããã¹ã«ãã€ãã«äžé
çæç©ã¯ãé£å¡©æ°Žã§æ¥å·ãããã®åŸäŸãã°ãžãšã
ã«ãšãŒãã«ããžã¯ããã¡ã¿ã³åã¯ãã³ãŒã³ã§æœåº
ããããšã«ããåé¢ãããã
ãŠããã¢ã«ãã«ååå¿ã¯ãé©åœãªæº¶åªäŸãã°ãã
ã©ããããã©ã³ããžãšãã«ãšãŒãã«ããããµã¡ã
ã«ãã¹ãã«ããªã¢ããããžã¡ãã«ã¹ã«ããã·ãã
åã¯ãã³ãŒã³äžã§çŽâ78ãã65âã®æž©åºŠç¯å²ã«ã
ããŠçŽ30åã24æéã«ããã€ãŠå®æœãããããžã
ã«ãªãã¡ãã«ã¢ã«ãã«å段éçšã«å¥œé©ãªæž©åºŠã¯çŽ
40âã§ãããã¢ã«ãã«åãããã¹ã«ãã€ãã«äžé
çæç©ã¯ãé£å¡©æ°Žã§æ¥å·ãããã®åŸäŸãã°ãžãšã
ã«ãšãŒãã«ããžã¯ããã¡ã¿ã³åã¯ãã³ãŒã³ã§æœåº
ããããšã«ããåé¢ãããã
ã¢ã«ãã«åãããã¹ã«ãã€ãã«èªå°äœã®ã±ãã³
ãžã®å æ°Žå解ã¯ã溶åªäŸãã°ããã©ããããã©
ã³ãã¢ã»ããããªã«ããžãšãã«ãšãŒãã«åã¯ãã³
ãŒã³äžã§çŽâ20ãã105âã«ãããŠã奜é©ã«ã¯çŽ
ïŒæéã«ããã€ãŠãæ°Žæ§é±é žãäŸãã°å¡©é žãèå
æ°ŽçŽ é žãéå¡©çŽ é žåã¯ç¡«é žãçšããŠè¡ãªãããã
äžè¬ã«1.5ïŒ ã®æ°Žäžã®0.3åœéã®é±é žã䜿çšãã
ããç¹å®ã®å®æœäŸäžã«ãåŒã®ãžãã«ãªãã¡ãã«
ã±ãã³èªå°äœã®è£œé ãããã«èª¬æãããŠããã
ãžã®å æ°Žå解ã¯ã溶åªäŸãã°ããã©ããããã©
ã³ãã¢ã»ããããªã«ããžãšãã«ãšãŒãã«åã¯ãã³
ãŒã³äžã§çŽâ20ãã105âã«ãããŠã奜é©ã«ã¯çŽ
ïŒæéã«ããã€ãŠãæ°Žæ§é±é žãäŸãã°å¡©é žãèå
æ°ŽçŽ é žãéå¡©çŽ é žåã¯ç¡«é žãçšããŠè¡ãªãããã
äžè¬ã«1.5ïŒ ã®æ°Žäžã®0.3åœéã®é±é žã䜿çšãã
ããç¹å®ã®å®æœäŸäžã«ãåŒã®ãžãã«ãªãã¡ãã«
ã±ãã³èªå°äœã®è£œé ãããã«èª¬æãããŠããã
åŒã®ååç©ã¯ãåŒ
ãåŒäžãR1åã³R2ã¯åŒã§å®çŸ©ãããŠããåŠ
ãã§ããã ã®é©åœã«çœ®æãããã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿
ããŒã«èªå°äœããå¡©åºã®ååšäžã§ãçŽ25âã«ãã
ãŠãçŽïŒã20æéã«ããã€ãŠïœâãã«ãšã³ã¹ã«ã
ãã«ãã©ã€ããäŸãã°ïœâãã«ãšã³ã¹ã«ããã«ã¯
ãã©ã€ãã§åŠçããŠå¯Ÿå¿ããïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãäžãããããææ©å¡©
åºãäŸãã°ããªãšãã«ã¢ãã³ã®ååšäžã§çŽïŒãïŒ
æéã«ããã€ãŠçŽ25âã«ãããŠç¡æ°Žé ¢é žã§åŠçã
ãããšã«ãã補é ãããã
ãã§ããã ã®é©åœã«çœ®æãããã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿
ããŒã«èªå°äœããå¡©åºã®ååšäžã§ãçŽ25âã«ãã
ãŠãçŽïŒã20æéã«ããã€ãŠïœâãã«ãšã³ã¹ã«ã
ãã«ãã©ã€ããäŸãã°ïœâãã«ãšã³ã¹ã«ããã«ã¯
ãã©ã€ãã§åŠçããŠå¯Ÿå¿ããïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãäžãããããææ©å¡©
åºãäŸãã°ããªãšãã«ã¢ãã³ã®ååšäžã§çŽïŒãïŒ
æéã«ããã€ãŠçŽ25âã«ãããŠç¡æ°Žé ¢é žã§åŠçã
ãããšã«ãã補é ãããã
ãF3Câã§ããäžè¬åŒã®ååç©ã¯ãåŒã®
ååç©ã溶åªãäŸãã°çåæ°ŽçŽ é¡ãäŸãã°ãã³ãŒ
ã³ãããã¯ãã«ãšã³åã¯äœçŽã¢ã«ã³ãŒã«é¡äŸãã°
ã¡ã¿ããŒã«ãããã¯ãšã¿ããŒã«ãåã¯ã¢ã»ããã
ãªã«ãããã©ããããã©ã³ããžãšãã«ãšãŒãã«ã
ããã¯ãžã¡ããã·ãšã¿ã³äžã§ãçŽ25âã溶åªã®é
æµæž©åºŠã®éã®æž©åºŠã«ãããŠãçŽ10åã96æéã«ã
ãã€ãŠãããªããšãã«ãã¹ãã€ã³ã§åŠçããããš
ã«ãã補é ããããå·åŽãããšæ²ã§ããçæãã
ããã溶åªã§æŽæµãããããŠäŸãã°é ¢é žãšãã«ã
ã¢ã»ããããªã«åã¯äœçŽã¢ã«ã³ãŒã«ãçšããŠåçµ
æ¶åãããŠé©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡
ãã«ãã¹ãããŠã å¡©ãäžãããé©åœã«çœ®æããã
ïŒâã€ãããŸãªã«ã¡ãã«ãã¹ãããŠã å¡©ã¯é©åœã«
眮æãããïŒâã€ãããŸãªã«ã¡ã¿ããŒã«ãäžè¬ç
ã«äžèšã®ãã®ãšåãåå¿æ¡ä»¶ãçšããŠãããªããš
ãã«ãã¹ãããŠã å¡©ãäŸãã°ããªããšãã«ãã¹ã
ããŠã ãããã€ãã§åŠçããããšã«ãã€ãŠãåŸã
ãããé©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«
ããªããšãã«ãã¹ãããŠã å¡©ãã觊åªéã®ç¡é žç¬¬
äºéãå ããããŠãã液äœã¢ã³ã¢ãã¢äžã«æº¶è§£ã
ããŠããéå°éã®ïŒ25ïŒ ãŸã§ã®ïŒãããªãŠã åã¯
ãªããŠã éå±ã«æ¹æããªããçŽ10åãïŒæéã«ã
ãã€ãŠå ãããã®åŸäžæŽ»æ§é°å²æ°äŸãã°çªçŽ åã¯
ã¢ã«ãŽã³äžã§ã¢ã³ã¢ãã¢ãèžçºããããé©åœãªæº¶
åªãäŸãã°ãã³ãŒã³ããã«ãšã³ããžãšãã«ãšãŒã
ã«ãããã©ããããã©ã³åã¯ãžã¡ããã·ãšã¿ã³ã
å ãããããŠçæããïŒâã€ãããŸãªã«ã¡ããªã
ã³ãã¹ãã©ã³ãéãããïŒâã€ãããŸãªã«ã¡ããª
ãã³ãã¹ãã©ã³ãã溶åªäŸãã°ãã³ãŒã³ããã«ãš
ã³ããžãšãã«ãšãŒãã«ãããã©ããããã©ã³åã¯
ãžã¡ããã·ãšã¿ã³äžã§ãäžæŽ»æ§é°å²æ°äŸãã°çªçŽ
åã¯ã¢ã«ãŽã³äžã§ãçŽïŒâã溶åªã®éæµæž©åºŠã®é
ã®æž©åºŠã«ãããŠãçŽ30åã24æéã«ããã€ãŠããš
ã¹ãã«äŸãã°ããªãã«ãªãé ¢é žã®äœçŽã¢ã«ãã«ãš
ã¹ãã«ãäŸãã°ã¡ãã«ããšãã«ãïœâãããã«ã
ã€ãœãããã«åã¯ïœâããã«ãšã¹ãã«ã§åŠçãã
ãã®åŸåå¿æ··åç©ãæ¿çž®ããããŠèžçããŠãªã¬ã
ã€ã³ãäžãããããå ±æº¶åªäŸãã°ããã©ãããã
ã©ã³ããžãšãã«ãšãŒãã«åã¯ãã³ãŒã³ãçšããŠã
çŽ30åã24æéã«ããã€ãŠãçŽïŒâã溶åªã®éæµ
枩床ã®éã®æž©åºŠã«ãããŠãæ°Žæ§é±é žãäŸãã°å¡©é ž
ãããã¯èåæ°ŽçŽ é žåã¯ææ©é žãäŸãã°ããªãã«
ãªãé ¢é žãããã¯ïœâãã«ãšã³ã¹ã«ãã³é žã§åŠç
ãããé žã®äœ¿çšéã¯è§Šåªéããæ¿çž®é žãŸã§å€åã§
ããããF3Câã§ããäžèšã®åŒã®ååç©ã®è£œ
é ã§äœ¿çšãããååŠæ¹æ³ã¯äžè¬ã«ãããŒãšããã
ãããã³ïŒP.H.BetmannïŒã®Ang.Chem.1nt.
Ed.1966ïŒ308é ã«èšãããŠããã
ååç©ã溶åªãäŸãã°çåæ°ŽçŽ é¡ãäŸãã°ãã³ãŒ
ã³ãããã¯ãã«ãšã³åã¯äœçŽã¢ã«ã³ãŒã«é¡äŸãã°
ã¡ã¿ããŒã«ãããã¯ãšã¿ããŒã«ãåã¯ã¢ã»ããã
ãªã«ãããã©ããããã©ã³ããžãšãã«ãšãŒãã«ã
ããã¯ãžã¡ããã·ãšã¿ã³äžã§ãçŽ25âã溶åªã®é
æµæž©åºŠã®éã®æž©åºŠã«ãããŠãçŽ10åã96æéã«ã
ãã€ãŠãããªããšãã«ãã¹ãã€ã³ã§åŠçããããš
ã«ãã補é ããããå·åŽãããšæ²ã§ããçæãã
ããã溶åªã§æŽæµãããããŠäŸãã°é ¢é žãšãã«ã
ã¢ã»ããããªã«åã¯äœçŽã¢ã«ã³ãŒã«ãçšããŠåçµ
æ¶åãããŠé©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡
ãã«ãã¹ãããŠã å¡©ãäžãããé©åœã«çœ®æããã
ïŒâã€ãããŸãªã«ã¡ãã«ãã¹ãããŠã å¡©ã¯é©åœã«
眮æãããïŒâã€ãããŸãªã«ã¡ã¿ããŒã«ãäžè¬ç
ã«äžèšã®ãã®ãšåãåå¿æ¡ä»¶ãçšããŠãããªããš
ãã«ãã¹ãããŠã å¡©ãäŸãã°ããªããšãã«ãã¹ã
ããŠã ãããã€ãã§åŠçããããšã«ãã€ãŠãåŸã
ãããé©åœã«çœ®æãããïŒâã€ãããŸãªã«ã¡ãã«
ããªããšãã«ãã¹ãããŠã å¡©ãã觊åªéã®ç¡é žç¬¬
äºéãå ããããŠãã液äœã¢ã³ã¢ãã¢äžã«æº¶è§£ã
ããŠããéå°éã®ïŒ25ïŒ ãŸã§ã®ïŒãããªãŠã åã¯
ãªããŠã éå±ã«æ¹æããªããçŽ10åãïŒæéã«ã
ãã€ãŠå ãããã®åŸäžæŽ»æ§é°å²æ°äŸãã°çªçŽ åã¯
ã¢ã«ãŽã³äžã§ã¢ã³ã¢ãã¢ãèžçºããããé©åœãªæº¶
åªãäŸãã°ãã³ãŒã³ããã«ãšã³ããžãšãã«ãšãŒã
ã«ãããã©ããããã©ã³åã¯ãžã¡ããã·ãšã¿ã³ã
å ãããããŠçæããïŒâã€ãããŸãªã«ã¡ããªã
ã³ãã¹ãã©ã³ãéãããïŒâã€ãããŸãªã«ã¡ããª
ãã³ãã¹ãã©ã³ãã溶åªäŸãã°ãã³ãŒã³ããã«ãš
ã³ããžãšãã«ãšãŒãã«ãããã©ããããã©ã³åã¯
ãžã¡ããã·ãšã¿ã³äžã§ãäžæŽ»æ§é°å²æ°äŸãã°çªçŽ
åã¯ã¢ã«ãŽã³äžã§ãçŽïŒâã溶åªã®éæµæž©åºŠã®é
ã®æž©åºŠã«ãããŠãçŽ30åã24æéã«ããã€ãŠããš
ã¹ãã«äŸãã°ããªãã«ãªãé ¢é žã®äœçŽã¢ã«ãã«ãš
ã¹ãã«ãäŸãã°ã¡ãã«ããšãã«ãïœâãããã«ã
ã€ãœãããã«åã¯ïœâããã«ãšã¹ãã«ã§åŠçãã
ãã®åŸåå¿æ··åç©ãæ¿çž®ããããŠèžçããŠãªã¬ã
ã€ã³ãäžãããããå ±æº¶åªäŸãã°ããã©ãããã
ã©ã³ããžãšãã«ãšãŒãã«åã¯ãã³ãŒã³ãçšããŠã
çŽ30åã24æéã«ããã€ãŠãçŽïŒâã溶åªã®éæµ
枩床ã®éã®æž©åºŠã«ãããŠãæ°Žæ§é±é žãäŸãã°å¡©é ž
ãããã¯èåæ°ŽçŽ é žåã¯ææ©é žãäŸãã°ããªãã«
ãªãé ¢é žãããã¯ïœâãã«ãšã³ã¹ã«ãã³é žã§åŠç
ãããé žã®äœ¿çšéã¯è§Šåªéããæ¿çž®é žãŸã§å€åã§
ããããF3Câã§ããäžèšã®åŒã®ååç©ã®è£œ
é ã§äœ¿çšãããååŠæ¹æ³ã¯äžè¬ã«ãããŒãšããã
ãããã³ïŒP.H.BetmannïŒã®Ang.Chem.1nt.
Ed.1966ïŒ308é ã«èšãããŠããã
äžèšã®å®æœäŸã¯æ¬çºæãããã«èª¬æãããã®ã§
ããã
ããã
åèäŸ ïŒ
ïŒïŒïŒïŒâïŒïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒ
âã€ãããŸãªã«ïŒãšãã«ïŒã¢ããã¡ãã«ïŒããš
ãã«ïŒã¢ã»ãã«ã¢ããïŒâïŒâã¢ã»ãã«ãªãã·
ã¡ãã«âïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·
ã¯ããïŒïŒïŒïŒïŒããªã¯ããŒïŒâãšã³âïŒâã«
ã«ãã³é ž 1gã®ïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâããïŒâ
ãïŒâïŒã¯ããã¡ãã«ïŒããšãã«ãã¢ã»ãã«ãã¢
ãããâïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯
ãâãïŒïŒïŒïŒïŒããªã¯ãâïŒâãšã³âïŒâã«ã«
ãã³é žåã³1gã®ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒ
âã€ãããŸãªã«ïŒãšãã«ã¢ãã³ã®æ··åç©ã50mlã®
ãšã¿ããŒã«äžã§25âã«ãããŠ24æéã«ããã€ãŠæ¹
æãããã®åŸæº¶åªãé€ããšæ®æž£ãåŸãããããã
ã·ãªã«ã²ã«äžã§æº¶åºå€ãšããŠãã³ãŒã³âã¢ã»ãã³
ã䜿çšããŠã¯ãããã°ã©ãã«ãããŠæšèšã®ååç©
ãåŸãã
âã€ãããŸãªã«ïŒãšãã«ïŒã¢ããã¡ãã«ïŒããš
ãã«ïŒã¢ã»ãã«ã¢ããïŒâïŒâã¢ã»ãã«ãªãã·
ã¡ãã«âïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·
ã¯ããïŒïŒïŒïŒïŒããªã¯ããŒïŒâãšã³âïŒâã«
ã«ãã³é ž 1gã®ïŒâã¢ã»ãã«ãªãã·ã¡ãã«âïŒâããïŒâ
ãïŒâïŒã¯ããã¡ãã«ïŒããšãã«ãã¢ã»ãã«ãã¢
ãããâïŒâãªããœâïŒâãã¢âïŒâã¢ã¶ãã·ã¯
ãâãïŒïŒïŒïŒïŒããªã¯ãâïŒâãšã³âïŒâã«ã«
ãã³é žåã³1gã®ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒ
âã€ãããŸãªã«ïŒãšãã«ã¢ãã³ã®æ··åç©ã50mlã®
ãšã¿ããŒã«äžã§25âã«ãããŠ24æéã«ããã€ãŠæ¹
æãããã®åŸæº¶åªãé€ããšæ®æž£ãåŸãããããã
ã·ãªã«ã²ã«äžã§æº¶åºå€ãšããŠãã³ãŒã³âã¢ã»ãã³
ã䜿çšããŠã¯ãããã°ã©ãã«ãããŠæšèšã®ååç©
ãåŸãã
åèäŸ ïŒ
硬質ãŒã©ãã³ã«ãã»ã«çšã®ä»£è¡šççµæã以äžã«
èšãïŒ (a) ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸ
ãªã«ïŒâãšãã«ã¢ãã³ 20mg (b) æ»ç³ ïŒmg (c) ä¹³ç³ 90mg (a)åã³(b)ã®ä¹Ÿç¥ç²æ«ã埮现ã¡ãã·ãŠã¹ã¯ãªãŒã³
äžã«éãããããŠããããããæ··åããããšã«ã
ã調å€ã補é ãããç²æ«ã次ã«ç¡¬è³ªãŒã©ãã³ã«ã
ã»ã«äžã«ãïŒã«ãã»ã«åœã115mgã®å®è³ªå ãŠãé
ã§ãå ãŠãããã
èšãïŒ (a) ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸ
ãªã«ïŒâãšãã«ã¢ãã³ 20mg (b) æ»ç³ ïŒmg (c) ä¹³ç³ 90mg (a)åã³(b)ã®ä¹Ÿç¥ç²æ«ã埮现ã¡ãã·ãŠã¹ã¯ãªãŒã³
äžã«éãããããŠããããããæ··åããããšã«ã
ã調å€ã補é ãããç²æ«ã次ã«ç¡¬è³ªãŒã©ãã³ã«ã
ã»ã«äžã«ãïŒã«ãã»ã«åœã115mgã®å®è³ªå ãŠãé
ã§ãå ãŠãããã
åèäŸ ïŒ
é å€çšã®ä»£è¡šççµæã以äžã«èšãïŒ
(a) ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸ
ãªã«ïŒâãšãã«ã¢ãã³ 20mg (b) ã§ãã·ã 43mg (c) ä¹³ç³ 45mg (d) ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒmg ä¹³ç³ãååç©(a)åã³äžéšã®ã§ãã·ããšæ··åãã
ãããŠã§ãã·ãããŒã¹ããšå ±ã«ç²ç¶åãããé¡ç²
ã也ç¥ããã¹ã¯ãªãŒã³ã«ããããããŠã¹ãã¢ãªã³
é žãã°ãã·ãŠã ãšæ··åãããæ··åç©ãå§çž®ããŠã
ããã110mgã®ééã®é å€ã«ããã
ãªã«ïŒâãšãã«ã¢ãã³ 20mg (b) ã§ãã·ã 43mg (c) ä¹³ç³ 45mg (d) ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒmg ä¹³ç³ãååç©(a)åã³äžéšã®ã§ãã·ããšæ··åãã
ãããŠã§ãã·ãããŒã¹ããšå ±ã«ç²ç¶åãããé¡ç²
ã也ç¥ããã¹ã¯ãªãŒã³ã«ããããããŠã¹ãã¢ãªã³
é žãã°ãã·ãŠã ãšæ··åãããæ··åç©ãå§çž®ããŠã
ããã110mgã®ééã®é å€ã«ããã
åèäŸ ïŒ
泚å°æžæ¿æ¶²çšã®ä»£è¡šççµæã¯ãçèå
泚å°çšã®
äžèšã®ïŒmlã®ã¢ã³ãã«ã§ããã
äžèšã®ïŒmlã®ã¢ã³ãã«ã§ããã
ééïŒ
(a) ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸ
ãªã«ïŒâãšãã«ã¢ãã³ 1.0 (b) ããªããã«ãããªãã³ 0.5 (c) ã¬ã·ãã³ 0.25 (d) 泚å°çšã®æ°Žã§100.0ïŒ ãšãã ç©è³ª(a)ã(d)ãæ··åããå質åãããããŠïŒmlã®
ã¢ã³ãã«äžã«å ãŠããããããå¯å°ãã121âã«
ãããŠ20åéãªãŒãã¯ã¬ãŒãã«ããããåã¢ã³ã
ã«ã¯ïŒmlã®åœã10mgã®æ°èŠååç©(a)ãå«æããŠã
ãã
ãªã«ïŒâãšãã«ã¢ãã³ 1.0 (b) ããªããã«ãããªãã³ 0.5 (c) ã¬ã·ãã³ 0.25 (d) 泚å°çšã®æ°Žã§100.0ïŒ ãšãã ç©è³ª(a)ã(d)ãæ··åããå質åãããããŠïŒmlã®
ã¢ã³ãã«äžã«å ãŠããããããå¯å°ãã121âã«
ãããŠ20åéãªãŒãã¯ã¬ãŒãã«ããããåã¢ã³ã
ã«ã¯ïŒmlã®åœã10mgã®æ°èŠååç©(a)ãå«æããŠã
ãã
åèäŸ ïŒ
ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãª
ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é žå¡© (A) ïŒâã«å·åŽãããããŠç£æ°çã«æ¹æãããŠã
ãã84mlã®ãšãŒãã«äžã«29ããªã¢ã«ã®ãžã¢ãŸã¡
ã¿ã³ãå«ãã§ãã溶液ã«ã45åéã«ããã€ãŠã
60mlã®ãšãŒãã«äžã«4.32gïŒ14.5ããªã¢ã«ïŒã®
ïŒâãã·ã«âïŒâã€ãããŸãªã«ã¢ã»ãã«ã¯ãã©
ã€ããå«ãã§ãã溶液ã滎ã æ·»å ããã25âã«
ãããŠïŒïŒïŒïŒæéæ¹æããåŸã«ãåå¿æ··åç©ãã ïŒâã«ãããããå·åŽãããŠããå¡©åæ°ŽçŽ ïŒããª
ãžã³ã®æº¶æ¶²ã«å ãããçæããäžå質溶液ã
25âã«ãããŠïŒïŒïŒïŒæéæ¹æãã次ã«æ°·ïŒ150gïŒ äžã«æ³šãã ãææ©çžãåé¢ããçé žæ°ŽçŽ ãããªãŠ
ã ïŒPHïŒïŒïŒã§æŽæµãã次ã«é£å¡©æ°Žã§æŽæµããã
ããŠç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããæžå§äžã§æ··
åç©ãæ¿çž®ãããšãïŒâãã·ã«âïŒâã€ãããŸãª
ã«âã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ãåŸãããã
ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é žå¡© (A) ïŒâã«å·åŽãããããŠç£æ°çã«æ¹æãããŠã
ãã84mlã®ãšãŒãã«äžã«29ããªã¢ã«ã®ãžã¢ãŸã¡
ã¿ã³ãå«ãã§ãã溶液ã«ã45åéã«ããã€ãŠã
60mlã®ãšãŒãã«äžã«4.32gïŒ14.5ããªã¢ã«ïŒã®
ïŒâãã·ã«âïŒâã€ãããŸãªã«ã¢ã»ãã«ã¯ãã©
ã€ããå«ãã§ãã溶液ã滎ã æ·»å ããã25âã«
ãããŠïŒïŒïŒïŒæéæ¹æããåŸã«ãåå¿æ··åç©ãã ïŒâã«ãããããå·åŽãããŠããå¡©åæ°ŽçŽ ïŒããª
ãžã³ã®æº¶æ¶²ã«å ãããçæããäžå質溶液ã
25âã«ãããŠïŒïŒïŒïŒæéæ¹æãã次ã«æ°·ïŒ150gïŒ äžã«æ³šãã ãææ©çžãåé¢ããçé žæ°ŽçŽ ãããªãŠ
ã ïŒPHïŒïŒïŒã§æŽæµãã次ã«é£å¡©æ°Žã§æŽæµããã
ããŠç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããæžå§äžã§æ··
åç©ãæ¿çž®ãããšãïŒâãã·ã«âïŒâã€ãããŸãª
ã«âã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ãåŸãããã
(B) â10âã«å·åŽãããŠããã25mlã®ã¡ã¿ããŒã«
äžã«20ããªã¢ã«ã®ïŒâãã·ã«âïŒâã€ãããŸãª
ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ãå«ãã§ãã溶
液ãã30mgã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã§åŠçã
ããâ10ããïŒâã«ãããïŒæéåŸã«ãåå¿æ··
åç©ã6Mã®HClã§äžåããããŠç空äžã§æ¿çž®
ãããæ®æž£ãã¯ãããã«ã ã§æ°åæœåºããã溶
åªãèžçºããããšæ²¹ãåŸããããããé«ç空äž
ã§èžçã«ãã粟補ããŠïŒâãã«ãªãâïŒâïŒïŒ
âãã·ã«âïŒâã€ãããŸãªã«ïŒãããã³âïŒâ
ãªãŒã«ãåŸãã2.4gã®ããªããšãã«ãã¹ãã€ã³
åã³25mlã®ããã©ããããã©ã³äžã®2gã®ïŒâ
ãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãª
ã«ïŒãããã³âïŒâãªãŒã«ã1.37gã®ãã¿ã«ã€
ããåã³1.74gã®ãžãšãã«ã¢ãŸãžã«ã«ããã·ã¬
ãŒãã®æº¶æ¶²ãçªçŽ äžã§25âã«ãããŠ20æéã«ã
ãã€ãŠæ¹æãããã®åŸæº¶åªãæžå§äžã§èžçºã
ãããããŠæ®æž£ããã³ãŒã³äžã«å ãããäžæº¶æ§
ç©è³ªãããŠããããŠæžå§äžã§ã®æ¿Ÿæ¶²ã®æ¿çž®åŸã«
åŸãããååºäœæ®æž£ããžã¯ããã¡ã¿ã³ïŒãžãšã
ã«ãšãŒãã«ã䜿çšããŠåçµæ¶åãããŠãã«ãªã
ãã¿ã«ã€ããèªå°äœãåŸãã0.18gã®ããã©ãž
ã³æ°Žåç©äžã®1.12gã®ãã«ãªããã¿ã«ã€ããèª
å°äœã®æº¶æ¶²ã42mlã®ç¡æ°Žãšã¿ããŒã«äžã§ãéæµ
枩床ã«ãããŠïŒæéã«ããã€ãŠå ç±ãããå·åŽ
ãã溶液ãç空äžã§æ¿çž®ããŠ15mlã®å®¹éã«ãã
ïŒâã«ãããŠäžæ©æŸçœ®ãã次ã«æ¿Ÿéããã濟液
ãæ¿çž®ããé«ç空äžã§èžçããŠïŒâãã«ãªãã¡
ãã«âïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãªã«ïŒ
ãšãã«ã¢ãã³ãåŸããããïŒmlã®47ïŒ èåæ°ŽçŽ
ãšäžç·ã«ãã次ã«100âã«ãããŠçªçŽ äžã§ïŒæ
éå ç±ãããã®åŸæžå§äžã§æ¿çž®ãããšãåºäœæ®
枣ãåŸããããæ®æž£ããšã¿ããŒã«âãžãšãã«ãš
ãŒãã«ããåçµæ¶ããããšãïŒâãã«ãªãã¡ã
ã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ã¢ãã³è
åæ°ŽçŽ é žå¡©ãåŸãããã
äžã«20ããªã¢ã«ã®ïŒâãã·ã«âïŒâã€ãããŸãª
ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ãå«ãã§ãã溶
液ãã30mgã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã§åŠçã
ããâ10ããïŒâã«ãããïŒæéåŸã«ãåå¿æ··
åç©ã6Mã®HClã§äžåããããŠç空äžã§æ¿çž®
ãããæ®æž£ãã¯ãããã«ã ã§æ°åæœåºããã溶
åªãèžçºããããšæ²¹ãåŸããããããé«ç空äž
ã§èžçã«ãã粟補ããŠïŒâãã«ãªãâïŒâïŒïŒ
âãã·ã«âïŒâã€ãããŸãªã«ïŒãããã³âïŒâ
ãªãŒã«ãåŸãã2.4gã®ããªããšãã«ãã¹ãã€ã³
åã³25mlã®ããã©ããããã©ã³äžã®2gã®ïŒâ
ãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãª
ã«ïŒãããã³âïŒâãªãŒã«ã1.37gã®ãã¿ã«ã€
ããåã³1.74gã®ãžãšãã«ã¢ãŸãžã«ã«ããã·ã¬
ãŒãã®æº¶æ¶²ãçªçŽ äžã§25âã«ãããŠ20æéã«ã
ãã€ãŠæ¹æãããã®åŸæº¶åªãæžå§äžã§èžçºã
ãããããŠæ®æž£ããã³ãŒã³äžã«å ãããäžæº¶æ§
ç©è³ªãããŠããããŠæžå§äžã§ã®æ¿Ÿæ¶²ã®æ¿çž®åŸã«
åŸãããååºäœæ®æž£ããžã¯ããã¡ã¿ã³ïŒãžãšã
ã«ãšãŒãã«ã䜿çšããŠåçµæ¶åãããŠãã«ãªã
ãã¿ã«ã€ããèªå°äœãåŸãã0.18gã®ããã©ãž
ã³æ°Žåç©äžã®1.12gã®ãã«ãªããã¿ã«ã€ããèª
å°äœã®æº¶æ¶²ã42mlã®ç¡æ°Žãšã¿ããŒã«äžã§ãéæµ
枩床ã«ãããŠïŒæéã«ããã€ãŠå ç±ãããå·åŽ
ãã溶液ãç空äžã§æ¿çž®ããŠ15mlã®å®¹éã«ãã
ïŒâã«ãããŠäžæ©æŸçœ®ãã次ã«æ¿Ÿéããã濟液
ãæ¿çž®ããé«ç空äžã§èžçããŠïŒâãã«ãªãã¡
ãã«âïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãªã«ïŒ
ãšãã«ã¢ãã³ãåŸããããïŒmlã®47ïŒ èåæ°ŽçŽ
ãšäžç·ã«ãã次ã«100âã«ãããŠçªçŽ äžã§ïŒæ
éå ç±ãããã®åŸæžå§äžã§æ¿çž®ãããšãåºäœæ®
枣ãåŸããããæ®æž£ããšã¿ããŒã«âãžãšãã«ãš
ãŒãã«ããåçµæ¶ããããšãïŒâãã«ãªãã¡ã
ã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ã¢ãã³è
åæ°ŽçŽ é žå¡©ãåŸãããã
åèäŸ ïŒ
ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã·ã«ã€ãããŸãŒ
ã« (A) 40mlã®æ°Žäžã«0.08ã¢ã«ã®çé žæ°ŽçŽ ãããªãŠã
ãå«ãã§ããæ°·å·æº¶æ¶²ã«ã0.02ã¢ã«ã®ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«å¡©é žå¡©ãå ãããã®
åŸ30mlã®é ¢é žãšãã«äžã«0.025ã¢ã«ã®ãã·ã«ã¯
ãã©ã€ããå«ãã§ãã溶液ãå ãããåå¿æ··å
ç©ã宀枩ã«ãããŠïŒæéæ¹æãããææ©çžãå
é¢ããçé žæ°ŽçŽ ãããªãŠã ã§æŽæµããç¡«é žãã°
ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ã
ããæ®æž£ãé ¢é žãšãã«ããçµæ¶åãããŠãïŒâ
ãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãåŸ
ãã
ã« (A) 40mlã®æ°Žäžã«0.08ã¢ã«ã®çé žæ°ŽçŽ ãããªãŠã
ãå«ãã§ããæ°·å·æº¶æ¶²ã«ã0.02ã¢ã«ã®ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«å¡©é žå¡©ãå ãããã®
åŸ30mlã®é ¢é žãšãã«äžã«0.025ã¢ã«ã®ãã·ã«ã¯
ãã©ã€ããå«ãã§ãã溶液ãå ãããåå¿æ··å
ç©ã宀枩ã«ãããŠïŒæéæ¹æãããææ©çžãå
é¢ããçé žæ°ŽçŽ ãããªãŠã ã§æŽæµããç¡«é žãã°
ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ã
ããæ®æž£ãé ¢é žãšãã«ããçµæ¶åãããŠãïŒâ
ãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãåŸ
ãã
(B) 10mlã®ã¯ãããã«ã äžã«10ããªã¢ã«ã®ïŒâã
ã·ã«ã€ãããŸãŒã«âïŒâã€ã«âã¡ã¿ããŒã«ãå«
ãã§ãã溶液ã«ã20ããªã¢ã«ã®ããªãšãã«ã¢ã
ã³ã滎ã æ·»å ãããã®åŸ13ããªã¢ã«ã®ç¡æ°Žé ¢é ž
ãïŒæéãããŠæ·»å ããã25âã«ãããŠæ¹æã
ïŒæéç¶ãããã®åŸæº¶åªãæžå§äžã§é€ãããæ®
枣ãé ¢é žãšãã«åã³æ°Žã®éã«åé ãããææ©çž
ãçé žæ°ŽçŽ ãããªãŠã ã§æŽæµããç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããããŠç空äžã§èžçºãããã
æ®æž£ãé ¢é žãšãã«ããåçµæ¶åããããšãïŒâ
ã¢ã»ããã·ã¡ãã«âïŒâãã·ã«âã€ãããŸãŒã«
ãåŸãããã
ã·ã«ã€ãããŸãŒã«âïŒâã€ã«âã¡ã¿ããŒã«ãå«
ãã§ãã溶液ã«ã20ããªã¢ã«ã®ããªãšãã«ã¢ã
ã³ã滎ã æ·»å ãããã®åŸ13ããªã¢ã«ã®ç¡æ°Žé ¢é ž
ãïŒæéãããŠæ·»å ããã25âã«ãããŠæ¹æã
ïŒæéç¶ãããã®åŸæº¶åªãæžå§äžã§é€ãããæ®
枣ãé ¢é žãšãã«åã³æ°Žã®éã«åé ãããææ©çž
ãçé žæ°ŽçŽ ãããªãŠã ã§æŽæµããç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããããŠç空äžã§èžçºãããã
æ®æž£ãé ¢é žãšãã«ããåçµæ¶åããããšãïŒâ
ã¢ã»ããã·ã¡ãã«âïŒâãã·ã«âã€ãããŸãŒã«
ãåŸãããã
åèäŸ ïŒ
ãžãã«ãªãã¡ãã«âïŒâãã·ã«ã€ããããŸãŒã«
âïŒâã€ã«ã¡ãã«ã±ãã³ (A) 20mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã«10ããªã¢
ã«ã®ããïŒãšãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªã
ãšã¿ã³ãå«ãã§ãã溶液ããããã©ããããã©
ã³äž1Mãžã€ãœãããã«ã¢ãã³åã³ãããµã³äž
2Mããã«ãªããŠã 溶液ãã補é ããã10ããª
ã¢ã«ã®ãªããŠã ãžã€ãœãããã«ã¢ããã§ïŒâã«
æŒãŠåŠçãããïŒâã«ããã30åéåŸã«ã10ml
ã®ããã©ããããã©ã³äžã«12ããªã¢ã«ã®ïŒâã¢
ã»ãã«ãªãã·ã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«
ãå«ãã§ãã溶液ãå ãããåå¿æ··åç©ã25â
ã«ãããŠäžå€æ¹æãã次ã«é£å¡©æ°Žã§å·åŽããã
ããŠãšãŒãã«ã§æœåºãããææ©çžãé£å¡©æ°Žã§æŽ
æµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæž
å§äžã§æ¿çž®ãããšãããïŒãšãã«ã¹ã«ãã€ãã«ïŒ
âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã
ããªããšã¿ã³ãåŸãããã20mlã®ä¹Ÿç¥ããã©ã
ãããã©ã³äžã«20ããªã¢ã«ã®ããïŒãšãã«ã¹ã«ã
ã€ãã«ïŒâïŒâãã·ã«âã€ãããŸãŒã«âïŒâã€
ã«ã¡ãã«ãããªããšã¿ã³ãå«ãã§ãã溶液ã«ã
ïŒâã«ãããŠãããŠçªçŽ äžã§ãããã©ãããã
ã©ã³äž1Mãžã€ãœãããã«ã¢ãã³åã³ãããµã³
äž2Mããã«ãªããŠã 溶液ãã補é ããã20ã
ãªã¢ã«ã®ãªããŠã ãžã€ãœãããã«ã¢ããã®æº¶æ¶²
ãå ããã25âã«ãããŠ30åéæ¹æãç¶ããã
ã®åŸåå¿æ··åç©äžã«ã¯ãããžãã«ãªãã¡ã¿ã³æµ
ã1/2æéã«ããã€ãŠæ³¡ç«ãããŠå ãããåå¿
æ··åç©ã40âã§ïŒæéä¿ã¡ã次ã«é£å¡©æ°Žã§æ¥å·
ãããããŠãšãŒãã«ã§æœåºãããææ©çžãåé¢
ããé£å¡©æ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿ
ç¥ãããããŠæžå§äžã§æ¿çž®ãããšãããïŒãšãã«
ã¹ã«ãã€ãã«ïŒïŒïŒãžãã«ãªãã¡ãã«ïŒâïŒâã
ã·ã«âã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ïŒãã
ãªããšã¿ã³ãåŸãããã33mlã®ã¢ã»ããããªã«
äžã«30mlã®ããïŒãšãã«ã¹ã«ãã€ãã«ïŒïŒïŒãžãã«
ãªãã¡ãã«ïŒâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ïŒãããªããšã¿ã³ãå«ãã§ãã溶液
ã«ïŒâã«ãããŠãéå¡©çŽ é žã®70ïŒ æ°Žæº¶æ¶²ïŒ1.1
mlïŒãå ãããïŒâã«ãããŠïŒæéæ¹æããåŸ
ã«ãåå¿æ··åç©ã60mlã®æ°Žäžã«æ³šå ¥ãã次ã«ãž
ãã«ãªãã¡ã¿ã³ã§æœåºãããææ©çžãçé žæ°ŽçŽ
ãããªãŠã ã§æŽæµãã次ã«æ°Žã§æŽæµããç¡«é žã
ã°ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ã
ããšããžãã«ãªãã¡ãã«ïŒâã€ãããŸãªã«ã¡ã
ã«ã±ãã³ãåŸãããã
âïŒâã€ã«ã¡ãã«ã±ãã³ (A) 20mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã«10ããªã¢
ã«ã®ããïŒãšãã«ã¹ã«ãã€ãã«ïŒã¡ãã«ãããªã
ãšã¿ã³ãå«ãã§ãã溶液ããããã©ããããã©
ã³äž1Mãžã€ãœãããã«ã¢ãã³åã³ãããµã³äž
2Mããã«ãªããŠã 溶液ãã補é ããã10ããª
ã¢ã«ã®ãªããŠã ãžã€ãœãããã«ã¢ããã§ïŒâã«
æŒãŠåŠçãããïŒâã«ããã30åéåŸã«ã10ml
ã®ããã©ããããã©ã³äžã«12ããªã¢ã«ã®ïŒâã¢
ã»ãã«ãªãã·ã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«
ãå«ãã§ãã溶液ãå ãããåå¿æ··åç©ã25â
ã«ãããŠäžå€æ¹æãã次ã«é£å¡©æ°Žã§å·åŽããã
ããŠãšãŒãã«ã§æœåºãããææ©çžãé£å¡©æ°Žã§æŽ
æµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæž
å§äžã§æ¿çž®ãããšãããïŒãšãã«ã¹ã«ãã€ãã«ïŒ
âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã
ããªããšã¿ã³ãåŸãããã20mlã®ä¹Ÿç¥ããã©ã
ãããã©ã³äžã«20ããªã¢ã«ã®ããïŒãšãã«ã¹ã«ã
ã€ãã«ïŒâïŒâãã·ã«âã€ãããŸãŒã«âïŒâã€
ã«ã¡ãã«ãããªããšã¿ã³ãå«ãã§ãã溶液ã«ã
ïŒâã«ãããŠãããŠçªçŽ äžã§ãããã©ãããã
ã©ã³äž1Mãžã€ãœãããã«ã¢ãã³åã³ãããµã³
äž2Mããã«ãªããŠã 溶液ãã補é ããã20ã
ãªã¢ã«ã®ãªããŠã ãžã€ãœãããã«ã¢ããã®æº¶æ¶²
ãå ããã25âã«ãããŠ30åéæ¹æãç¶ããã
ã®åŸåå¿æ··åç©äžã«ã¯ãããžãã«ãªãã¡ã¿ã³æµ
ã1/2æéã«ããã€ãŠæ³¡ç«ãããŠå ãããåå¿
æ··åç©ã40âã§ïŒæéä¿ã¡ã次ã«é£å¡©æ°Žã§æ¥å·
ãããããŠãšãŒãã«ã§æœåºãããææ©çžãåé¢
ããé£å¡©æ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿ
ç¥ãããããŠæžå§äžã§æ¿çž®ãããšãããïŒãšãã«
ã¹ã«ãã€ãã«ïŒïŒïŒãžãã«ãªãã¡ãã«ïŒâïŒâã
ã·ã«âã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ïŒãã
ãªããšã¿ã³ãåŸãããã33mlã®ã¢ã»ããããªã«
äžã«30mlã®ããïŒãšãã«ã¹ã«ãã€ãã«ïŒïŒïŒãžãã«
ãªãã¡ãã«ïŒâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ïŒãããªããšã¿ã³ãå«ãã§ãã溶液
ã«ïŒâã«ãããŠãéå¡©çŽ é žã®70ïŒ æ°Žæº¶æ¶²ïŒ1.1
mlïŒãå ãããïŒâã«ãããŠïŒæéæ¹æããåŸ
ã«ãåå¿æ··åç©ã60mlã®æ°Žäžã«æ³šå ¥ãã次ã«ãž
ãã«ãªãã¡ã¿ã³ã§æœåºãããææ©çžãçé žæ°ŽçŽ
ãããªãŠã ã§æŽæµãã次ã«æ°Žã§æŽæµããç¡«é žã
ã°ãã·ãŠã äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ã
ããšããžãã«ãªãã¡ãã«ïŒâã€ãããŸãªã«ã¡ã
ã«ã±ãã³ãåŸãããã
(B) åèäŸïŒ(A)ã®æ¹æ³ã«ãããŠãã€ãããŸãŒã«â
ïŒâã€ã«ã¡ã¿ããŒã«å¡©é žå¡©ã®ä»£ãã«é©åœéã®äž
èšã®éé¢å¡©åºãã補é ããããžãã«ãªãã¡ãã«
ïŒâã€ãããŸãªã«ã¡ãã«ã±ãã³å¡©é žå¡©ã䜿çš
ãããããŠçé žæ°ŽçŽ ãããªãŠã ã®ä»£ãã«é©åœé
ã®ããªãšãã«ã¢ãã³ã䜿çšãããšãã«ã¯ããžã
ã«ãªãã¡ãã«ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€
ã«ã¡ãã«ã±ãã³ãåŸãããã
ïŒâã€ã«ã¡ã¿ããŒã«å¡©é žå¡©ã®ä»£ãã«é©åœéã®äž
èšã®éé¢å¡©åºãã補é ããããžãã«ãªãã¡ãã«
ïŒâã€ãããŸãªã«ã¡ãã«ã±ãã³å¡©é žå¡©ã䜿çš
ãããããŠçé žæ°ŽçŽ ãããªãŠã ã®ä»£ãã«é©åœé
ã®ããªãšãã«ã¢ãã³ã䜿çšãããšãã«ã¯ããžã
ã«ãªãã¡ãã«ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€
ã«ã¡ãã«ã±ãã³ãåŸãããã
åèäŸ ïŒ
ããªãã«ãªãã¡ãã«ïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ã±ãã³ 20ããªã¢ã«ã®ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã·
ã«ã€ãããŸãŒã«åã³22ããªã¢ã«ã®ããªããšãã«ã
ã¹ãã€ã³ã®æ··åç©ã100mlã®ãã³ãŒã³äžã§éæµæž©
床ã«ïŒæ¥éå ç±ãããå·åŽãããšåé¢ããåºäœã
æ¿Ÿéãããã³ãŒã³ã§æŽæµããæžå§äžã§ä¹Ÿç¥ããã
ããŠ100mlã®æ¶²äœã¢ã³ã¢ãã¢äžã«20ããªã¢ã«ã®ã
ããªãŠã ã¢ãããå«ãã§ãã溶液ïŒè§Šåªéã®ç¡é ž
第äºéã®ååšäžã§æ¶²äœã¢ã³ã¢ãã¢ã«0.46gã®ãã
ãªãŠã ã«å ããããšã«ãã補é ãããïŒã«ãã€ã
ããšå ããã10åéæ¹æããåŸã«ãã¢ã³ã¢ãã¢ã
çªçŽ æµã®äžã§èžçºããããæ®æž£ã«100mlã®ç¡æ°Žã
ã³ãŒã³ãå ãããããŠäžå質混åç©ãéæµæž©åºŠã§
10åéå ç±ãããåºäœæ®æž£ãæ¿ŸéãããããŠå¡©ã
å«ãŸãªãïŒâãã·ã«âïŒâã€ãããŸãªã«ã¡ããªã
ã³ããªããšãã«ãã¹ãã©ã³ãå«æããŠãã濟液ã«
5.10-2Mã®ãšãã«ããªãã«ãªãã¢ã»ããŒããå ã
ããåå¿æ··åç©ãéæµæž©åºŠã«çªçŽ äžã§12æéå ç±
ããã溶åªãæ¿çž®ãããšãæ®æž£ãæ®ãããããé«
ç空äžã§èžçãããšãïŒâãšããã·âïŒïŒïŒïŒïŒ
âããªãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãã
ãŸãªã«ïŒãããâïŒâãšã³ãåŸãããã50mlã®ãš
ãŒãã«äžã«3gã®ïŒâãšããã·âïŒïŒïŒïŒïŒâã
ãªãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãª
ã«ïŒãããâïŒâãšã³ãå«ãã§ãã溶液ãã50ml
ã®æ°Žäžã«1Mã®ç¡«é žãå«ãã§ãã溶液ã§åŠçã
ããåå¿æ··åç©ã25âã§1/2æéæ¹æããããšãŒ
ãã«çžãåé¢ããé£å¡©æ°Žã§æŽæµããç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããããŠæ¿çž®ãããšãããªãã«ãª
ãã¡ãã«ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã
ã«ã±ãã³ãåŸãããã
ïŒâã€ã«ã¡ãã«ã±ãã³ 20ããªã¢ã«ã®ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã·
ã«ã€ãããŸãŒã«åã³22ããªã¢ã«ã®ããªããšãã«ã
ã¹ãã€ã³ã®æ··åç©ã100mlã®ãã³ãŒã³äžã§éæµæž©
床ã«ïŒæ¥éå ç±ãããå·åŽãããšåé¢ããåºäœã
æ¿Ÿéãããã³ãŒã³ã§æŽæµããæžå§äžã§ä¹Ÿç¥ããã
ããŠ100mlã®æ¶²äœã¢ã³ã¢ãã¢äžã«20ããªã¢ã«ã®ã
ããªãŠã ã¢ãããå«ãã§ãã溶液ïŒè§Šåªéã®ç¡é ž
第äºéã®ååšäžã§æ¶²äœã¢ã³ã¢ãã¢ã«0.46gã®ãã
ãªãŠã ã«å ããããšã«ãã補é ãããïŒã«ãã€ã
ããšå ããã10åéæ¹æããåŸã«ãã¢ã³ã¢ãã¢ã
çªçŽ æµã®äžã§èžçºããããæ®æž£ã«100mlã®ç¡æ°Žã
ã³ãŒã³ãå ãããããŠäžå質混åç©ãéæµæž©åºŠã§
10åéå ç±ãããåºäœæ®æž£ãæ¿ŸéãããããŠå¡©ã
å«ãŸãªãïŒâãã·ã«âïŒâã€ãããŸãªã«ã¡ããªã
ã³ããªããšãã«ãã¹ãã©ã³ãå«æããŠãã濟液ã«
5.10-2Mã®ãšãã«ããªãã«ãªãã¢ã»ããŒããå ã
ããåå¿æ··åç©ãéæµæž©åºŠã«çªçŽ äžã§12æéå ç±
ããã溶åªãæ¿çž®ãããšãæ®æž£ãæ®ãããããé«
ç空äžã§èžçãããšãïŒâãšããã·âïŒïŒïŒïŒïŒ
âããªãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãã
ãŸãªã«ïŒãããâïŒâãšã³ãåŸãããã50mlã®ãš
ãŒãã«äžã«3gã®ïŒâãšããã·âïŒïŒïŒïŒïŒâã
ãªãã«ãªãâïŒâïŒïŒâãã·ã«âïŒâã€ãããŸãª
ã«ïŒãããâïŒâãšã³ãå«ãã§ãã溶液ãã50ml
ã®æ°Žäžã«1Mã®ç¡«é žãå«ãã§ãã溶液ã§åŠçã
ããåå¿æ··åç©ã25âã§1/2æéæ¹æããããšãŒ
ãã«çžãåé¢ããé£å¡©æ°Žã§æŽæµããç¡«é žãã°ãã·
ãŠã äžã§ä¹Ÿç¥ãããããŠæ¿çž®ãããšãããªãã«ãª
ãã¡ãã«ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã
ã«ã±ãã³ãåŸãããã
åèäŸ ïŒ
ïŒâã€ãœãããã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ 200mlã®å·ããå¡©åããªãã«ã«ã0.1ã¢ã«ã®ïŒâ
ã€ãœãããã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«
ãå ããã25âã§ïŒæéæ¹æããåŸã«ãéå°éã®
å¡©åããªãã«ãæžå§äžã§èžçºããããšãç²è£œã®ïŒ
âã¯ããã¡ãã«âïŒâã€ãœãããã«ã€ãããŸãŒã«
å¡©é žå¡©ãåŸãããã25mlã®ä¹Ÿç¥ãžã¡ãã«ãã«ã ã¢
ããäžã«ïŒããªã¢ã«ã®ïŒâã¯ããã¡ãã«âïŒâã€
ãœãããã«ã€ãããŸãŒã«å¡©é žå¡©ãå«ãã§ããæ°·å·
溶液ã«ã30mlã®ãžã¡ãã«ãã«ã ã¢ããäžã«ç²æ«ç¶
ã·ã¢ã³åãããªãŠã ïŒ18ããªã¢ã«ïŒãå«ãã§ãã
å·æº¶æ¶²ãå ãããæ··åç©ã25âã§äžæ©æ¹æãã次
ã«200mlã®æ°Žã§åžéãããããŠçé žæ°ŽçŽ ãããªãŠ
ã ã§äžåããã溶液ã«å¡©åãããªãŠã ã飜åã
ãããããŠé ¢é žãšãã«ã§æœåºãããææ©æœåºç©ã
æ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããã
ãŠæžå§äžã§èžçºããããšãåºäœã®æ®æž£ãåŸããã
ãããæè¯ãããŠãïŒâã·ã¢ãã¡ãã«âïŒâã€ãœ
ãããã«ã€ãããŸãŒã«ãäžãããïŒâã·ã¢ãã¡ã
ã«âïŒâã€ãœãããã«ã€ãããŸãŒã«ïŒ10ããªã¢
ã«ïŒã10mlã®æ¿å¡©é žãšå ±ã«éæµæž©åºŠã§12æéå ç±
ãã次ã«æžå§äžã§æ¿çž®ããŠïŒâã€ãœãããã«ã€ã
ããŸãŒã«âïŒâã€ã«é ¢é žå¡©é žå¡©ãäžããã40mlã®
æ°Žäžã«0.08ã¢ã«ã®çé žãããªãŠã ãå«ãã§ããæ°·
å·æº¶æ¶²ã«ãïŒâã€ãœãããã«âã€ãããŸãŒã«âïŒ
âã€ã«é ¢é žå¡©é žå¡©ãå ãã次ã«30mlã®é ¢é žãšãã«
äžã«æº¶è§£ãããŠãã0.025ã¢ã«ã®ãã·ã«ã¯ãã©ã€
ããå ããã25âã§ïŒæéæ¹æããåŸã«ãåå¿æ··
åç©ã1Må¡©é žã§äžåãããããŠé ¢é žãšãã«ã§æœ
åºãããææ©çžãæ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã
äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ãããšãïŒâã€
ãœãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«
é ¢é žãåŸãããã100mlã®ãã³ãŒã³äžã«ïŒâã€ãœ
ãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«é ¢
é žã®ãããªãŠã å¡©ãå«ãã§ããæžæ¿æ¶²ã«ãïŒåœé
ã®å¡©åãªããµãªã«ãå ãããåå¿æ··åç©ã25âã«
ãããŠ12æéæ¹æãããæ²ã§ããæ¿Ÿå¥ãããããŠ
濟液ãæžå§äžã§æ¿çž®ãããšãïŒâã€ãœãããã«â
ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¢ã»ãã«ã¯ã
ã©ã€ããåŸãããã84mlã®ãšãŒãã«äžã«29ããªã¢
ã«ã®ãžã¢ãŸã¡ã¿ã³ãå«ãã§ããïŒâã«å·åŽããã
ããŠç£æ°çã«æ¹æãããŠãã溶液ã«ã60mlã®ãšãŒ
ãã«äžã«14.3ããªã¢ã«ã®ïŒâã€ãœãããã«âïŒâ
ãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¢ã»ãã«ã¯ãã©ã€
ããå«ãã§ãã溶液ã45åéã«ããã€ãŠæ»Žã æ·»å
ããã25âã«ãããŠïŒ1/2æéæ¹æããåŸã«ãå
å¿æ··åç©ããïŒâã«ãããããå·åŽãããŠããåŒ
åæ°ŽçŽ ïŒããªãžã³ã®æº¶æ¶²ã«å ãããçæããäžå
質溶液ã25âã«ãããŠïŒ1/2æéã«ããã€ãŠæ¹æ
ãã次ã«150gã®æ°·äžã«æ³šãã ãææ©çžãåé¢
ããçé žæ°ŽçŽ ãããªãŠã ïŒPHïŒïŒã§æŽæµãã次ã«
é£å¡©æ°Žã§æŽæµãããããŠç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿ
ç¥ãããæ··åç©ãæžå§äžã§æ¿çž®ãããšãïŒâã€ãœ
ãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡
ãã«ãã«ãªãã¡ãã«ã±ãã³ãåŸãããã
ïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ 200mlã®å·ããå¡©åããªãã«ã«ã0.1ã¢ã«ã®ïŒâ
ã€ãœãããã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«
ãå ããã25âã§ïŒæéæ¹æããåŸã«ãéå°éã®
å¡©åããªãã«ãæžå§äžã§èžçºããããšãç²è£œã®ïŒ
âã¯ããã¡ãã«âïŒâã€ãœãããã«ã€ãããŸãŒã«
å¡©é žå¡©ãåŸãããã25mlã®ä¹Ÿç¥ãžã¡ãã«ãã«ã ã¢
ããäžã«ïŒããªã¢ã«ã®ïŒâã¯ããã¡ãã«âïŒâã€
ãœãããã«ã€ãããŸãŒã«å¡©é žå¡©ãå«ãã§ããæ°·å·
溶液ã«ã30mlã®ãžã¡ãã«ãã«ã ã¢ããäžã«ç²æ«ç¶
ã·ã¢ã³åãããªãŠã ïŒ18ããªã¢ã«ïŒãå«ãã§ãã
å·æº¶æ¶²ãå ãããæ··åç©ã25âã§äžæ©æ¹æãã次
ã«200mlã®æ°Žã§åžéãããããŠçé žæ°ŽçŽ ãããªãŠ
ã ã§äžåããã溶液ã«å¡©åãããªãŠã ã飜åã
ãããããŠé ¢é žãšãã«ã§æœåºãããææ©æœåºç©ã
æ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ãããã
ãŠæžå§äžã§èžçºããããšãåºäœã®æ®æž£ãåŸããã
ãããæè¯ãããŠãïŒâã·ã¢ãã¡ãã«âïŒâã€ãœ
ãããã«ã€ãããŸãŒã«ãäžãããïŒâã·ã¢ãã¡ã
ã«âïŒâã€ãœãããã«ã€ãããŸãŒã«ïŒ10ããªã¢
ã«ïŒã10mlã®æ¿å¡©é žãšå ±ã«éæµæž©åºŠã§12æéå ç±
ãã次ã«æžå§äžã§æ¿çž®ããŠïŒâã€ãœãããã«ã€ã
ããŸãŒã«âïŒâã€ã«é ¢é žå¡©é žå¡©ãäžããã40mlã®
æ°Žäžã«0.08ã¢ã«ã®çé žãããªãŠã ãå«ãã§ããæ°·
å·æº¶æ¶²ã«ãïŒâã€ãœãããã«âã€ãããŸãŒã«âïŒ
âã€ã«é ¢é žå¡©é žå¡©ãå ãã次ã«30mlã®é ¢é žãšãã«
äžã«æº¶è§£ãããŠãã0.025ã¢ã«ã®ãã·ã«ã¯ãã©ã€
ããå ããã25âã§ïŒæéæ¹æããåŸã«ãåå¿æ··
åç©ã1Må¡©é žã§äžåãããããŠé ¢é žãšãã«ã§æœ
åºãããææ©çžãæ°Žã§æŽæµããç¡«é žãã°ãã·ãŠã
äžã§ä¹Ÿç¥ãããããŠæžå§äžã§æ¿çž®ãããšãïŒâã€
ãœãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«
é ¢é žãåŸãããã100mlã®ãã³ãŒã³äžã«ïŒâã€ãœ
ãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«é ¢
é žã®ãããªãŠã å¡©ãå«ãã§ããæžæ¿æ¶²ã«ãïŒåœé
ã®å¡©åãªããµãªã«ãå ãããåå¿æ··åç©ã25âã«
ãããŠ12æéæ¹æãããæ²ã§ããæ¿Ÿå¥ãããããŠ
濟液ãæžå§äžã§æ¿çž®ãããšãïŒâã€ãœãããã«â
ïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¢ã»ãã«ã¯ã
ã©ã€ããåŸãããã84mlã®ãšãŒãã«äžã«29ããªã¢
ã«ã®ãžã¢ãŸã¡ã¿ã³ãå«ãã§ããïŒâã«å·åŽããã
ããŠç£æ°çã«æ¹æãããŠãã溶液ã«ã60mlã®ãšãŒ
ãã«äžã«14.3ããªã¢ã«ã®ïŒâã€ãœãããã«âïŒâ
ãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¢ã»ãã«ã¯ãã©ã€
ããå«ãã§ãã溶液ã45åéã«ããã€ãŠæ»Žã æ·»å
ããã25âã«ãããŠïŒ1/2æéæ¹æããåŸã«ãå
å¿æ··åç©ããïŒâã«ãããããå·åŽãããŠããåŒ
åæ°ŽçŽ ïŒããªãžã³ã®æº¶æ¶²ã«å ãããçæããäžå
質溶液ã25âã«ãããŠïŒ1/2æéã«ããã€ãŠæ¹æ
ãã次ã«150gã®æ°·äžã«æ³šãã ãææ©çžãåé¢
ããçé žæ°ŽçŽ ãããªãŠã ïŒPHïŒïŒã§æŽæµãã次ã«
é£å¡©æ°Žã§æŽæµãããããŠç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿ
ç¥ãããæ··åç©ãæžå§äžã§æ¿çž®ãããšãïŒâã€ãœ
ãããã«âïŒâãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡
ãã«ãã«ãªãã¡ãã«ã±ãã³ãåŸãããã
åèäŸ 10
åèäŸïŒã®æ¹æ³ã«ãããŠãã€ãããŸãŒã«âïŒâ
ã€ã«âã¡ã¿ããŒã«ã®ä»£ãã«é©åœéã®ïŒâãã«ãªã
ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒïŒïŒâãž
ã¡ãã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒïŒ
ïŒâã€ãœãããã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ã
ãŒã«ãïŒâã€ãœãããã«âïŒâãšãã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ã¿ããŒã«åã¯ïŒâãã«ãªãâã€ã
ããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ã䜿çšãããšãã«
ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã«ãªãâïŒâã
ã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒïŒïŒâãžã¡ãã«âïŒ
âãã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒïŒïŒâãžã€ãœããã
ã«âïŒâãã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒâã€ãœãããã«âïŒ
âãã·ã«ã€ãããŸãŒã«ãåã³ ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã«ãªãâïŒâã
ã·ã«ã€ãããŸãŒã«ã
ã€ã«âã¡ã¿ããŒã«ã®ä»£ãã«é©åœéã®ïŒâãã«ãªã
ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒïŒïŒâãž
ã¡ãã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒïŒ
ïŒâã€ãœãããã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ã
ãŒã«ãïŒâã€ãœãããã«âïŒâãšãã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ã¿ããŒã«åã¯ïŒâãã«ãªãâã€ã
ããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ã䜿çšãããšãã«
ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã«ãªãâïŒâã
ã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒïŒïŒâãžã¡ãã«âïŒ
âãã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒïŒïŒâãžã€ãœããã
ã«âïŒâãã·ã«ã€ãããŸãŒã«ã ïŒâã¢ã»ããã·ã¡ãã«âïŒâã€ãœãããã«âïŒ
âãã·ã«ã€ãããŸãŒã«ãåã³ ïŒâã¢ã»ããã·ã¡ãã«âïŒâãã«ãªãâïŒâã
ã·ã«ã€ãããŸãŒã«ã
åèäŸ 11
åèäŸïŒ(A)ã®æ¹æ³ã«ãããŠãïŒâã¢ã»ããã·ã¡
ãã«âïŒâãã·ã«ã€ãããŸãŒã«ã®ä»£ãã«é©åœéã®
åèäŸ10ã§åŸãããã€ãããŸãŒã«ååç©ã䜿çšã
ããšãã«ã¯ãããããäžèšã®ã±ãã³ååç©ãåŸã
ããïŒ ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãž
ãã«ãªãã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã¡ãã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã€ãœãããã«ã€ã
ããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒâã€ãœãããã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ãã«ã±ãã³åã³ ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãž
ãã«ãªãã¡ãã«ã±ãã³ã
ãã«âïŒâãã·ã«ã€ãããŸãŒã«ã®ä»£ãã«é©åœéã®
åèäŸ10ã§åŸãããã€ãããŸãŒã«ååç©ã䜿çšã
ããšãã«ã¯ãããããäžèšã®ã±ãã³ååç©ãåŸã
ããïŒ ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãž
ãã«ãªãã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã¡ãã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã€ãœãããã«ã€ã
ããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒâã€ãœãããã«ã€ãããŸãŒ
ã«âïŒâã€ã«ã¡ãã«ã±ãã³åã³ ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãž
ãã«ãªãã¡ãã«ã±ãã³ã
åèäŸ 12
åèäŸïŒ(A)ã®æ¹æ³ã«ãããŠãã€ãããŸãŒã«âïŒ
âã€ã«ã¡ã¿ããŒã«ã®ä»£ãã«é©åœéã®å®æœäŸ11ã§åŸ
ãããã±ãã³ååç©ã®å¡©é žå¡©ã䜿çšãããšãã«
ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãžãã«ãªãã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã¡ãã«âïŒâãã·
ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã€ãœãããã«âïŒ
âãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒâã€ãœãããã«âïŒâãã·
ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãžãã«ãªãã±ãã³ã
âã€ã«ã¡ã¿ããŒã«ã®ä»£ãã«é©åœéã®å®æœäŸ11ã§åŸ
ãããã±ãã³ååç©ã®å¡©é žå¡©ã䜿çšãããšãã«
ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãžãã«ãªãã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã¡ãã«âïŒâãã·
ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒïŒïŒâãžã€ãœãããã«âïŒ
âãã·ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ã ãžãã«ãªãã¡ãã«ïŒâã€ãœãããã«âïŒâãã·
ã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ãã«ã±ãã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãžãã«ãªãã±ãã³ã
åèäŸ 13
åèäŸïŒã®æ¹æ³ã«ãããŠãïŒâã¢ã»ããã·ã¡ã
ã«âïŒâãã·ã«ã€ãããŸãŒã«ã®ä»£ãã«é©åœéã®å
èäŸ10ã§åŸãããã€ãããŸãŒã«ååç©ã䜿çšãã
ãšãã«ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã€ãœãããã«âïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ã
ã³ã ïŒâã€ãœãããã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã
ã«âïŒâãã·ã«ã€ãããŸãŒã«ã®ä»£ãã«é©åœéã®å
èäŸ10ã§åŸãããã€ãããŸãŒã«ååç©ã䜿çšãã
ãšãã«ã¯ãããããäžèšã®ååç©ãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã€ãœãããã«âïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ã
ã³ã ïŒâã€ãœãããã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ããªãã«ãªãã¡ãã«ã±ãã³ã
åèäŸ 14
åèäŸïŒã®æé ã«ãããŠãïŒâã€ãœãããã«ã€
ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ã®ä»£ãã«ãé©åœ
éã®ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ã
ãŒã«ãïŒïŒïŒâãžã¡ãã«âã€ãããŸãŒã«âïŒâã€
ã«ã¡ã¿ããŒã«ãïŒïŒïŒâãžã€ãœãããã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒâã€ãœãããã«â
ïŒâãšãã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«å
ã¯ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒ
ã«ã䜿çšãããšãã«ã¯ãããããäžèšã®ã±ãã³èª
å°äœãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã€ãœãããã«âïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒâã€ãœãããã«âïŒâãšãã«âïŒâãã·ã«ã€
ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ã
ã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã
ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ã®ä»£ãã«ãé©åœ
éã®ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ã
ãŒã«ãïŒïŒïŒâãžã¡ãã«âã€ãããŸãŒã«âïŒâã€
ã«ã¡ã¿ããŒã«ãïŒïŒïŒâãžã€ãœãããã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ã¿ããŒã«ãïŒâã€ãœãããã«â
ïŒâãšãã«ã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒã«å
ã¯ïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ã¡ã¿ããŒ
ã«ã䜿çšãããšãã«ã¯ãããããäžèšã®ã±ãã³èª
å°äœãåŸãããïŒ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã¡ãã«âïŒâãã·ã«ã€ãããŸãŒã«â
ïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒïŒïŒâãžã€ãœãããã«âïŒâãã·ã«ã€ãããŸ
ãŒã«âïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã ïŒâã€ãœãããã«âïŒâãšãã«âïŒâãã·ã«ã€
ãããŸãŒã«âïŒâã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ã
ã³ãåã³ ïŒâãã«ãªãâïŒâãã·ã«ã€ãããŸãŒã«âïŒâ
ã€ã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã
åèäŸ 15
åèäŸïŒ(B)ã®æ¹æ³ã«ãããŠãïŒâãã·ã«âïŒâ
ã€ãããŸãªã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã®ä»£ã
ã«ãé©åœéã®åèäŸ12ïŒ13åã³14ã§åŸãããã±ã
ã³ååç©ã䜿çšãããšãã«ã¯ãããããäžèšã®å
åç©ãåŸãããïŒ ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâãžãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã¡ã
ã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°Ž
çŽ é žå¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã€ãœ
ãããã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³
èåæ°ŽçŽ é žå¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãœããã
ã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°Ž
çŽ é žå¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâãžãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâïŒïŒïŒïŒâãžã¡ãã«ã€ãããŸãŒã«âïŒâã€
ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èå
æ°ŽçŽ é žå¡©ã ïŒâïŒïŒïŒïŒâãžã€ãœãããã«ã€ãããŸãŒã«â
ïŒâã€ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ã
ã³èåæ°ŽçŽ é žå¡©ã ïŒâïŒïŒâã€ãœãããã«ã€ãããŸãŒã«âïŒâã€
ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èå
æ°ŽçŽ é žå¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâãã«ãªãã€ã
ããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã¡ãã«
ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã€ãœã
ããã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³è
åæ°ŽçŽ é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãœãããã«
âïŒâãšãã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢
ãã³èåæ°ŽçŽ é žå¡©ãåã³ ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâãã«ãªãã€ã
ããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã
ã€ãããŸãªã«ã¡ãã«ãã«ãªãã¡ãã«ã±ãã³ã®ä»£ã
ã«ãé©åœéã®åèäŸ12ïŒ13åã³14ã§åŸãããã±ã
ã³ååç©ã䜿çšãããšãã«ã¯ãããããäžèšã®å
åç©ãåŸãããïŒ ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâãžãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã¡ã
ã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°Ž
çŽ é žå¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã€ãœ
ãããã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³
èåæ°ŽçŽ é žå¡©ã ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãœããã
ã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°Ž
çŽ é žå¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâãžãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâïŒïŒïŒïŒâãžã¡ãã«ã€ãããŸãŒã«âïŒâã€
ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èå
æ°ŽçŽ é žå¡©ã ïŒâïŒïŒïŒïŒâãžã€ãœãããã«ã€ãããŸãŒã«â
ïŒâã€ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ã
ã³èåæ°ŽçŽ é žå¡©ã ïŒâïŒïŒâã€ãœãããã«ã€ãããŸãŒã«âïŒâã€
ã«ïŒâïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èå
æ°ŽçŽ é žå¡©ã ïŒâïŒïŒâãã«ãªãã€ãããŸãŒã«âïŒâã€ã«ïŒ
âïŒâããªãã«ãªãã¡ãã«ãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâãã«ãªãã€ã
ããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã¡ãã«
ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ
é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒïŒïŒâãžã€ãœã
ããã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³è
åæ°ŽçŽ é žå¡©ã ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãœãããã«
âïŒâãšãã«ã€ãããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢
ãã³èåæ°ŽçŽ é žå¡©ãåã³ ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâãã«ãªãã€ã
ããŸãŒã«âïŒâã€ã«ïŒãšãã«ã¢ãã³èåæ°ŽçŽ é ž
å¡©ã
åèäŸ 16
âãïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãã
ãŸãªã«ïŒãšãã«ãã¢ã»ãã¢ãã 26mlã®2Mæ°Žé žåãããªãŠã äžã«10ããªã¢ã«ã®
ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãšãã«ã¢ãã³èåæ°ŽçŽ å¡©ãå«ãã§ãã溶液ããïŒ
âã«å·åŽããããã®æº¶æ¶²ã«ãïŒåã®æ³šå°åšãã13
ããªã¢ã«ã®å¡©åã¢ã»ãã«åã³ïŒmlã®2Mæ°Žé žåã
ããªãŠã 溶液ãåæã«æ»Žã æ·»å ãããïŒæéåŸ
ã«ã16mlã®1Må¡©é žã®æ·»å ã«ãã溶液ãäžåãã
次ã«èžçºä¹Ÿåºãããæ®æž£ããžã¯ããã¡ã¿ã³ãšå ±ã«
ç²ç ããæ¿ŸéãããããŠèžçºããããšãâïŒïŒ
âãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãšãã«ãã¢ã»ãã¢ãããåŸããããããé ¢é žãšã
ã«ããåçµæ¶åãããã
ãŸãªã«ïŒãšãã«ãã¢ã»ãã¢ãã 26mlã®2Mæ°Žé žåãããªãŠã äžã«10ããªã¢ã«ã®
ïŒâãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãšãã«ã¢ãã³èåæ°ŽçŽ å¡©ãå«ãã§ãã溶液ããïŒ
âã«å·åŽããããã®æº¶æ¶²ã«ãïŒåã®æ³šå°åšãã13
ããªã¢ã«ã®å¡©åã¢ã»ãã«åã³ïŒmlã®2Mæ°Žé žåã
ããªãŠã 溶液ãåæã«æ»Žã æ·»å ãããïŒæéåŸ
ã«ã16mlã®1Må¡©é žã®æ·»å ã«ãã溶液ãäžåãã
次ã«èžçºä¹Ÿåºãããæ®æž£ããžã¯ããã¡ã¿ã³ãšå ±ã«
ç²ç ããæ¿ŸéãããããŠèžçºããããšãâïŒïŒ
âãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒ
ãšãã«ãã¢ã»ãã¢ãããåŸããããããé ¢é žãšã
ã«ããåçµæ¶åãããã
äžèšã®æ¹æ³ã«ãããŠãå¡©åã¢ã»ãã«ã®ä»£ãã«é©
åœéã®ãã³ãžã«ã¯ãããã«ã¡ãŒãã䜿çšãããšã
ã«ã¯ããã³ãžã«ïŒ®âãïŒâãã«ãªãã¡ãã«âïŒâ
ïŒïŒâã€ãããŸãªã«ïŒãšãã«ãã«ã«ãã¡ãŒããåŸ
ãããã
åœéã®ãã³ãžã«ã¯ãããã«ã¡ãŒãã䜿çšãããšã
ã«ã¯ããã³ãžã«ïŒ®âãïŒâãã«ãªãã¡ãã«âïŒâ
ïŒïŒâã€ãããŸãªã«ïŒãšãã«ãã«ã«ãã¡ãŒããåŸ
ãããã
åèäŸ 17
âãïŒâãã«ãªãã¡ãã«âïŒâãïŒâã€ãã
ãŸãªã«ããšãã«ãâïŒâã¢ããããããªã³ã¢ã
ã 1.1gã®ããªãšãã«ã¢ãã³ãå«æããŠãã20mlã®
å¡©åã¡ãã¬ã³äžã«10ããªã¢ã«ã®ãã³ãžã«ïŒ®âãïŒ
âãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãš
ãã«ãã«ã«ãã¡ãŒããå«ãã§ãã溶液ã«ã10ããª
ã¢ã«ã®ãã³ãžã«ã¯ãããã«ã¡ãŒããå ããã25â
ã«ãããïŒæéåŸã«ã溶液ãæ°Žåã³1Nå¡©é žã§æŽ
æµãã次ã«èžçºããããšãžã«ã«ããã³ãŸãã·èªå°
äœãåŸãããããã®æ®æž£ã«30mlã®ãžãªããµã³äž
100ïŒééïŒééïŒïŒ èåæ°ŽçŽ ãå ãããããŠæ··
åç©ã25âã«ãããŠ30åéæŸçœ®ãããã®åŸ150ml
ã®ãšãŒãã«ãå ãããçæããæ²ã§ããæ¿Ÿå¥ãã
ãããŠçé žæ°ŽçŽ å¡©å·æº¶æ¶²ã«å ãã次ã«ãžã¯ããã¡
ã¿ã³ã§æ¥éã«æœåºããã也ç¥ããææ©çžãæ¿çž®ã
ããšãïŒâã«ã«ããã³ãŸãã·âïŒâãïŒâãã«ãª
ãã¡ãã«âïŒâã¢ãããšãã«ãâã€ãããŸãŒã«ã
åŸãããããã10mlã®ãžã¯ããã¡ã¿ã³äžã§1.6g
ïŒïŒããªã¢ã«ïŒã®ïŒ®âã«ã«ããã³ãŸãã·ã¢ã©ãã³
åã³1.45gïŒïŒããªã¢ã«ïŒã®ïŒ®ïŒïŒ®âãžã·ã¯ãã
ãã·ã«ã«ã«ããžã€ããã§25âã«ãããŠçŽ16æéåŠ
çããã次ã«æ··åç©ãïŒâã«å·åŽããããŠæ¿Ÿéã
ããææ©æº¶æ¶²ã1Nå¡©é žåã³çé žæ°ŽçŽ å¡©æº¶æ¶²ã§æŽ
æµãã次ã«ä¹Ÿç¥ãããããŠæ¿çž®ãããæ®æž£ããžãª
ããµã³äž30mlã®100ïŒééïŒééïŒïŒ èåæ°ŽçŽ ã§
25âã«ãããŠ30åéåŠçããã150mlã®ãšãŒãã«
ãæ·»å ãããšèåæ°ŽçŽ é žå¡©ãæ²ã§ããããããæ¿Ÿ
å¥ãããããŠ25âã«ãããŠçŽ16æéã«ããã€ãŠ50
mlã®1Næ°Žé žåãããªãŠã ã§åŠçãããçæãã
溶液ã®PHãäžæ§ã«èª¿ç¯ãããããŠçæç©ãã¢ã³ã
ã¢ã©ã€ã120H+æš¹èãã2Mã¢ã³ã¢ãã¢ãçšãã
溶é¢ã«ããåé¢ãããšãâãïŒâãã«ãªãã¡ã
ã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ãâïŒâã¢
ããããããªã³ã¢ãããåŸãããã
ãŸãªã«ããšãã«ãâïŒâã¢ããããããªã³ã¢ã
ã 1.1gã®ããªãšãã«ã¢ãã³ãå«æããŠãã20mlã®
å¡©åã¡ãã¬ã³äžã«10ããªã¢ã«ã®ãã³ãžã«ïŒ®âãïŒ
âãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãš
ãã«ãã«ã«ãã¡ãŒããå«ãã§ãã溶液ã«ã10ããª
ã¢ã«ã®ãã³ãžã«ã¯ãããã«ã¡ãŒããå ããã25â
ã«ãããïŒæéåŸã«ã溶液ãæ°Žåã³1Nå¡©é žã§æŽ
æµãã次ã«èžçºããããšãžã«ã«ããã³ãŸãã·èªå°
äœãåŸãããããã®æ®æž£ã«30mlã®ãžãªããµã³äž
100ïŒééïŒééïŒïŒ èåæ°ŽçŽ ãå ãããããŠæ··
åç©ã25âã«ãããŠ30åéæŸçœ®ãããã®åŸ150ml
ã®ãšãŒãã«ãå ãããçæããæ²ã§ããæ¿Ÿå¥ãã
ãããŠçé žæ°ŽçŽ å¡©å·æº¶æ¶²ã«å ãã次ã«ãžã¯ããã¡
ã¿ã³ã§æ¥éã«æœåºããã也ç¥ããææ©çžãæ¿çž®ã
ããšãïŒâã«ã«ããã³ãŸãã·âïŒâãïŒâãã«ãª
ãã¡ãã«âïŒâã¢ãããšãã«ãâã€ãããŸãŒã«ã
åŸãããããã10mlã®ãžã¯ããã¡ã¿ã³äžã§1.6g
ïŒïŒããªã¢ã«ïŒã®ïŒ®âã«ã«ããã³ãŸãã·ã¢ã©ãã³
åã³1.45gïŒïŒããªã¢ã«ïŒã®ïŒ®ïŒïŒ®âãžã·ã¯ãã
ãã·ã«ã«ã«ããžã€ããã§25âã«ãããŠçŽ16æéåŠ
çããã次ã«æ··åç©ãïŒâã«å·åŽããããŠæ¿Ÿéã
ããææ©æº¶æ¶²ã1Nå¡©é žåã³çé žæ°ŽçŽ å¡©æº¶æ¶²ã§æŽ
æµãã次ã«ä¹Ÿç¥ãããããŠæ¿çž®ãããæ®æž£ããžãª
ããµã³äž30mlã®100ïŒééïŒééïŒïŒ èåæ°ŽçŽ ã§
25âã«ãããŠ30åéåŠçããã150mlã®ãšãŒãã«
ãæ·»å ãããšèåæ°ŽçŽ é žå¡©ãæ²ã§ããããããæ¿Ÿ
å¥ãããããŠ25âã«ãããŠçŽ16æéã«ããã€ãŠ50
mlã®1Næ°Žé žåãããªãŠã ã§åŠçãããçæãã
溶液ã®PHãäžæ§ã«èª¿ç¯ãããããŠçæç©ãã¢ã³ã
ã¢ã©ã€ã120H+æš¹èãã2Mã¢ã³ã¢ãã¢ãçšãã
溶é¢ã«ããåé¢ãããšãâãïŒâãã«ãªãã¡ã
ã«âïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ãâïŒâã¢
ããããããªã³ã¢ãããåŸãããã
å®æœäŸïŒåã³ïŒ
åèäŸïŒ(B)ã®æé ã«åŸã€ãŠå¯Ÿå¿ããã±ãã³åå
ç©ã䜿çšã次ã®ååç©ãåŸãã
ç©ã䜿çšã次ã®ååç©ãåŸãã
å®æœäŸ ïŒ
ã¢ã«ãã¢ãŒïŒããªãã«ãªãã¡ãã«ïŒâ1Hâã€
ãããŸãŒã«âïŒâãšã¿ããã³äºå¡©é žå¡© èç¹ 241ã245â å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãª
ã«ïŒâãšãã«ã¢ãã³å¡©é žå¡© èç¹ 208ã210â
ãããŸãŒã«âïŒâãšã¿ããã³äºå¡©é žå¡© èç¹ 241ã245â å®æœäŸ ïŒ ïŒâãžãã«ãªãã¡ãã«âïŒâïŒïŒâã€ãããŸãª
ã«ïŒâãšãã«ã¢ãã³å¡©é žå¡© èç¹ 208ã210â
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ãåŒäžãã¯F2CHâåã¯F3Câã§ããã ã®ååç©ã䞊ã³ã«ããã®è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©
åã³åå åŠçç°æ§äœã ïŒ ïŒ¹ãF2CHâãå³ã¡ïŒâãžãã«ãªãã¡ãã«â
ïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ã¢ãã³åã¯ãã
ã®è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©ã§ãããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒ¹ãF3Câãå³ã¡ïŒâããªãã«ãªãã¡ãã«â
ïŒâïŒïŒâã€ãããŸãªã«ïŒãšãã«ã¢ãã³åã¯ãã
ã®è£œè¬çã«èš±å®¹å¯èœãªå¡©ã§ãããç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®ååç©ã ïŒ ä»¥äžã®åŒ ã®ïŒâã€ãããŸãªã«ããã¡ãã«ã±ãã³èªå°äœãå
åŠçåã¯æ¥è§Šçã«éå ããŠå¯Ÿå¿ããã¢ã«ã³ãŒã«ãš
ãããããé©åœãªæº¶åªäžã§çŽïŒãã100âã«ãã
ãŠçŽ1/2ã24æéã«ããã€ãŠäžæŽ»æ§é°å²æ°äžã§ïŒ
åœéã®é©åœãªã€ããã1.1åœéã®é©åœãªãã¹ãã€
ã³åã³1.1åœéã®ãžãšãã«ã¢ãŸãžã«ã«ããã·ã¬ãŒ
ãã§åŠçãããã®åŸå æ°Žå解ãã補è¬åŠçã«èš±å®¹
å¯èœãªå¡©ãåžæãããšãã«ã¯ããã®ããã«ããŠåŸ
ãããååç©ã補è¬åŠçã«èš±å®¹å¯èœãªé žãšåå¿ã
ããããšãããªãåŒ ãåŒäžãã¯F2CHâåã¯F3Câã§ãããã ã®ååç©ã䞊ã³ã«ããã®è£œè¬åŠçã«èš±å®¹å¯èœãªå¡©
åã³åå åŠçç°æ§äœã®è£œæ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84365977A | 1977-10-19 | 1977-10-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5466676A JPS5466676A (en) | 1979-05-29 |
| JPS6223753B2 true JPS6223753B2 (ja) | 1987-05-25 |
Family
ID=25290634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12746678A Granted JPS5466676A (en) | 1977-10-19 | 1978-10-18 | Alphaahalomethylderivative of histamine and relative compounds |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5466676A (ja) |
| AU (1) | AU522245B2 (ja) |
| BE (1) | BE871356A (ja) |
| CA (1) | CA1111432A (ja) |
| CH (1) | CH637384A5 (ja) |
| DE (1) | DE2844104A1 (ja) |
| ES (1) | ES474321A1 (ja) |
| FR (1) | FR2406631A1 (ja) |
| GB (1) | GB2007231B (ja) |
| IT (1) | IT1106448B (ja) |
| NL (1) | NL7810173A (ja) |
| NZ (1) | NZ188498A (ja) |
| ZA (1) | ZA785435B (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009184686A (ja) * | 2008-02-04 | 2009-08-20 | Mitsubishi Heavy Industries Food & Packaging Machinery Co Ltd | ããŒã¿ãªãŒå å¡«æ©åã³ããŒã¿ãªãŒå å¡«æ©ã®å å¡«æ¹æ³ |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1302919C (en) * | 1985-07-03 | 1992-06-09 | Robert T. Buckler | Histamine derivatives, immunogen conjugates and antibodies raised thereto |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5416422A (en) * | 1977-06-01 | 1979-02-07 | Merck & Co Inc | 11fluoromethyl substitutedd alkylamine and process for preparing same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE920250C (de) * | 1951-09-19 | 1954-11-18 | Hoffmann La Roche | Verfahren zur Herstellung von 4-(ªÂ-Amino-ªÂ-brompropyl)-imidazolsalzen |
| DE1161903B (de) * | 1960-08-19 | 1964-01-30 | Merck & Co Inc | Verfahren zur Herstellung von antihistaminisch wirksamem ªâ¡-Methyl-dl-histidin |
| FR1457259A (fr) * | 1961-08-18 | 1966-01-24 | Merck & Co Inc | Production d'amino-acides du type alpha-alkyl-histidine |
-
1978
- 1978-09-25 NZ NZ188498A patent/NZ188498A/xx unknown
- 1978-09-25 ZA ZA00785435A patent/ZA785435B/xx unknown
- 1978-09-26 CA CA312,083A patent/CA1111432A/en not_active Expired
- 1978-10-10 NL NL7810173A patent/NL7810173A/xx not_active Application Discontinuation
- 1978-10-10 DE DE19782844104 patent/DE2844104A1/de not_active Withdrawn
- 1978-10-13 AU AU40706/78A patent/AU522245B2/en not_active Expired
- 1978-10-13 CH CH1066078A patent/CH637384A5/de not_active IP Right Cessation
- 1978-10-16 GB GB7840731A patent/GB2007231B/en not_active Expired
- 1978-10-17 IT IT51542/78A patent/IT1106448B/it active
- 1978-10-18 BE BE191193A patent/BE871356A/xx not_active IP Right Cessation
- 1978-10-18 ES ES474321A patent/ES474321A1/es not_active Expired
- 1978-10-18 FR FR7829697A patent/FR2406631A1/fr active Granted
- 1978-10-18 JP JP12746678A patent/JPS5466676A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5416422A (en) * | 1977-06-01 | 1979-02-07 | Merck & Co Inc | 11fluoromethyl substitutedd alkylamine and process for preparing same |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009184686A (ja) * | 2008-02-04 | 2009-08-20 | Mitsubishi Heavy Industries Food & Packaging Machinery Co Ltd | ããŒã¿ãªãŒå å¡«æ©åã³ããŒã¿ãªãŒå å¡«æ©ã®å å¡«æ¹æ³ |
Also Published As
| Publication number | Publication date |
|---|---|
| CH637384A5 (de) | 1983-07-29 |
| ES474321A1 (es) | 1980-01-16 |
| DE2844104A1 (de) | 1979-04-26 |
| BE871356A (fr) | 1979-02-15 |
| AU4070678A (en) | 1980-04-17 |
| FR2406631B1 (ja) | 1980-09-19 |
| IT1106448B (it) | 1985-11-11 |
| NL7810173A (nl) | 1979-04-23 |
| GB2007231A (en) | 1979-05-16 |
| JPS5466676A (en) | 1979-05-29 |
| AU522245B2 (en) | 1982-05-27 |
| ZA785435B (en) | 1979-09-26 |
| NZ188498A (en) | 1980-08-26 |
| FR2406631A1 (fr) | 1979-05-18 |
| IT7851542A0 (it) | 1978-10-17 |
| GB2007231B (en) | 1982-03-24 |
| CA1111432A (en) | 1981-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880002310B1 (ko) | íìíì¬ ì믌ë¥ì ì ì¡°ë°©ë² | |
| JP4259615B2 (ja) | è¬ç©åžžçšããã³ç¹ã«ã¢ã«ã³ãŒã«äžæ¯ã®æ²»å¯®ãžã®Î³âããããã·é ªé žã¢ããã®äœ¿çš | |
| JPH05320162A (ja) | ããããæ§ããã¯ãªãžã³ | |
| MXPA03011448A (es) | Derivados de n-arilfenilacetamida y composicion farmaceutica que los contienen. | |
| JPH07502742A (ja) | ïœïœâã¬ã»ãã¿æ®æå€ãšããŠã®ã¢ããé žèªå°äœ | |
| BRPI0719187A2 (pt) | Composto heterocÃclicos úteis como agentes anábolicos para animais de criação | |
| BRPI0810399B1 (pt) | composto, composição farmacêutica que o contém e uso do mesmo | |
| JPS636058B2 (ja) | ||
| US20230029009A1 (en) | Chemical compounds | |
| WO2003080556A1 (fr) | Derive d'amine a fonction regulatrice des canaux potassiques, sa preparation et son utilisation | |
| JP7169592B2 (ja) | ïœïœïŒå容äœæ®æè¬ãçšããé®çè¬ | |
| JP2846895B2 (ja) | æçæ£çšãŸãã¯ç¥çµä¿è·çšå»è¬ | |
| JP2004501901A (ja) | ã€ããããªããžã³ç³»ïœïœïœïœïœïœïŒïœå容äœæ®æè¬ | |
| JPH11228411A (ja) | æ»ççã®æ²»çæ³ | |
| EA003941B1 (ru) | 2-аЌОМПпОÑОЎОМÑ, ÑПЎеÑжаÑОе кПМЎеМÑОÑПваММÑе кПлÑÑа в каÑеÑÑве заЌеÑÑОÑелей | |
| US4103089A (en) | α-Acetylene and α-vinyl derivatives of amino acids | |
| JPS6223753B2 (ja) | ||
| CN111925313B (zh) | å ·æpde4æå¶æŽ»æ§çååç©ãå¶å€æ¹æ³ãç»åç©åçšé | |
| CA1120041A (en) | .alpha.-HALOMETHYL DERIVATIVES OF AMINO ACIDS | |
| WO2019232662A1 (zh) | äžç±»å ·ææç掻æ§çå²åªç±»ååç©åå ¶è¡çç© | |
| KR100437561B1 (ko) | ì ê·í€í ë¡ê³ 늬íí©ë¬Œ | |
| US4221914A (en) | Alpha-halomethyl derivatives of histamine and related compounds | |
| US4100349A (en) | α-Acetylenic derivatives of histamine and related compounds | |
| JPH0692948A (ja) | æ°èŠãªã¢ã»ã¿ããèªå°äœåã³ãã®çšé | |
| US20040133001A1 (en) | Peptide deformylase inhibitors |